<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Tissue Barriers</journal-id><journal-id journal-id-type="iso-abbrev">Tissue Barriers</journal-id><journal-id journal-id-type="publisher-id">TB</journal-id><journal-title-group><journal-title>Tissue Barriers</journal-title></journal-title-group><issn pub-type="ppub">2168-8362</issn><issn pub-type="epub">2168-8370</issn><publisher><publisher-name>Landes Bioscience</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24665393</article-id><article-id pub-id-type="pmc">3879235</article-id><article-id pub-id-type="publisher-id">2013TISSBARRIER026R1</article-id><article-id pub-id-type="doi">10.4161/tisb.24783</article-id><article-id pub-id-type="pii">24783</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Cleavage of transmembrane junction proteins and their role in regulating epithelial homeostasis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Nava</surname><given-names>Porfirio</given-names></name><xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="A2">
<sup>2</sup>
</xref><xref ref-type="author-notes" rid="afn0">
<sup>&#x02020;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kamekura</surname><given-names>Ryuta</given-names></name><xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref><xref ref-type="author-notes" rid="afn0">
<sup>&#x02020;</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nusrat</surname><given-names>Asma</given-names></name><xref ref-type="aff" rid="A1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff id="A1"><label>1</label>Epithelial Pathobiology and Mucosal Inflammation Research Unit; Department of Pathology and Laboratory Medicine; Emory University School of Medicine; Atlanta, GA USA</aff><aff id="A2"><label>2</label>Department of Physiology; Biophysics and Neurosciences; Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV); M&#x000e9;xico DF, Mexico</aff></contrib-group><author-notes><fn id="afn0"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn><corresp id="cor1"><label>*</label>Correspondence to: Asma Nusrat, Email: <email xlink:href="anusrat@emory.edu">anusrat@emory.edu</email></corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>4</month><year>2013</year></pub-date><pub-date pub-type="epub"><day>01</day><month>4</month><year>2013</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>4</month><year>2013</year></pub-date><volume>1</volume><issue>2</issue><elocation-id>e24783</elocation-id><history><date date-type="received"><day>13</day><month>3</month><year>2013</year></date><date date-type="rev-recd"><day>19</day><month>4</month><year>2013</year></date><date date-type="accepted"><day>23</day><month>4</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Landes Bioscience</copyright-statement><copyright-year>2013</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions><abstract><p>Epithelial tissues form a selective barrier that separates the external environment from the internal tissue milieu. Single epithelial cells are densely packed and associate via distinct intercellular junctions. Intercellular junction proteins not only control barrier properties of the epithelium but also play an important role in regulating epithelial homeostasis that encompasses cell proliferation, migration, differentiation and regulated shedding. Recent studies have revealed that several proteases target epithelial junction proteins during physiological maturation as well as in pathologic states such as inflammation and cancer. This review discusses mechanisms and biological consequences of transmembrane junction protein cleavage. The influence of junction protein cleavage products on pathogenesis of inflammation and cancer is discussed.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords: </title><kwd>epithelia</kwd><kwd>intercellular junctions</kwd><kwd>cleavage of junction proteins</kwd><kwd>epithelial homeostasis</kwd><kwd>proteases</kwd><kwd>soluble junction protein ectodomains</kwd><kwd>protein shedding</kwd><kwd>mucosal inflammation</kwd><kwd>inflammatory bowel disease</kwd><kwd>cancer</kwd></kwd-group></article-meta></front><body><sec><title>Introduction</title><p>Epithelial tissues form a physical barrier that separates the external environment and tissue compartments thereby playing a pivotal role in host defense. In simple epithelia such as in the gut, this barrier is formed by a single layer of cells joined by a series of intercellular junctions: tight junctions (TJs), adherens junctions (AJs) and desmosomes (DMs).<xref ref-type="bibr" rid="R1"><sup>1</sup></xref> Intercellular junctions affiliate with the cytoskeleton that in turn controls junction function. It is now evident that intercellular junctions are dynamic structures that not only control the epithelial barrier, but also influence overall epithelial homeostasis.</p><p>TJs, the most apical epithelial junctions, are visualized as belt-like structures in a region where membranes from adjoining cells comes into very close apposition forming a selective seal that regulates paracellular movement of ions and solutes.<xref ref-type="bibr" rid="R1"><sup>1</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R2"><sup>2</sup></xref> In addition to its role as a gate, TJs also function as a fence that prevents free movement of proteins from the apical to the basolateral membrane. Thus, TJs contribute to maintenance of epithelial apical-basolateral polarity.<xref ref-type="bibr" rid="R2"><sup>2</sup></xref> A vast repertoire of TJ proteins have been identified that can be broadly grouped into transmembrane, cytoplasmic plaque and signaling proteins. Key transmembrane proteins include claudins, occludin/tricellulin and the cortical thymocyte marker in Xenopus (CTX) family members (junctional adhesion molecule A (JAM-A), coxsackie adenovirus receptor (CAR) and CAR-like membrane protein (CLMP)). These transmembrane proteins affiliate with the underlying apical perijunctional F-actin belt via peripheral membrane proteins, such as zonula occludens (ZO)-1 and membrane-associated guanylate kinase with inverted orientation (MAGI)-1.<xref ref-type="bibr" rid="R2"><sup>2</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R6"><sup>6</sup></xref></p><p>AJs are localized immediately subjacent to the TJ and by electron microscopy appear as regions where membranes of two neighboring cells run parallel to each other.<xref ref-type="bibr" rid="R1"><sup>1</sup></xref> Analogous to TJs, AJs circumscribe the cell periphery and play an important role regulating cell-cell adhesion. AJs consist of a central core of transmembrane proteins that include nectin, classical cadherin family members such as epithelial (E)-cadherin, neural (N)-cadherin, placental (P)-cadherin and cytoplasmic plaque proteins, which are linked to the actin cytoskeleton via plaque proteins.<xref ref-type="bibr" rid="R7"><sup>7</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R8"><sup>8</sup></xref> Plaque proteins in the AJ include afadin/AF-6 (for nectin), &#x003b1;-catenin and several members of the armadillo family that include &#x003b2;-catenin and p120-catenin (for classical cadherin).<xref ref-type="bibr" rid="R8"><sup>8</sup></xref> It is noteworthy to mention that the AJ plaque protein &#x003b2;-catenin is one of the principal transcription factors that regulate epithelial proliferation and differentiation.<xref ref-type="bibr" rid="R9"><sup>9</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R10"><sup>10</sup></xref> Thus, establishment and maintenance of functional AJs is a central event that controls epithelial homeostasis.</p><p>DMs are spot-like adhesions located in the lateral membrane of the epithelial cells<xref ref-type="bibr" rid="R11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R12"><sup>12</sup></xref> and comprised of desmosomal cadherins: desmoglein (Dsg) and desmocollin (Dsc). To date, four isoforms of Dsg (Dsg1&#x02013;4) and three isoforms of Dsc (Dsc1&#x02013;3) have been identified in the human epidermis.<xref ref-type="bibr" rid="R13"><sup>13</sup></xref> However, simple epithelia such as intestinal epithelium expresses only Dsg2 and Dsc2.<xref ref-type="bibr" rid="R12"><sup>12</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R14"><sup>14</sup></xref> Desmosomal cadherins indirectly associate with keratin intermediate filaments via plaque proteins, that include plakoglobin, plakophilin and the plakin family member, desmoplakin.<xref ref-type="bibr" rid="R11"><sup>11</sup></xref> DMs provide resistance to mechanical stress in the epithelium and also in several nonepithelial tissues such as cardiac muscle and meninges.<xref ref-type="bibr" rid="R12"><sup>12</sup></xref> In concert with other intercellular junctions, DMs are reservoirs for signaling molecules that control several biological processes.<xref ref-type="bibr" rid="R11"><sup>11</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R14"><sup>14</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R15"><sup>15</sup></xref> Dysfunction of desmosomal cadherins has been linked to pathogenesis of diseases such as pemphigus vulgaris.<xref ref-type="bibr" rid="R16"><sup>16</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R18"><sup>18</sup></xref></p><p>Given their essential role in maintenance of the epithelial barrier, cell junctions need to function as dynamic structures that are continuously assembled and disassembled. The dynamic nature of cell junctions allows epithelial cells to respond to external stimuli by modifying strength and distribution of cell junction proteins. Remodeling of cell junctions can be achieved by mechanisms that include: de novo synthesis,<xref ref-type="bibr" rid="R19"><sup>19</sup></xref> internalization,<xref ref-type="bibr" rid="R20"><sup>20</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R21"><sup>21</sup></xref> exocytosis<xref ref-type="bibr" rid="R22"><sup>22</sup></xref> and proteolytic processing of structural proteins at cell junctions.<xref ref-type="bibr" rid="R14"><sup>14</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R23"><sup>23</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R24"><sup>24</sup></xref> Indeed, proteolysis of transmembrane junction proteins by cellular and bacterial proteases has emerged as a novel mechanism to regulate intercellular junctions and epithelial homeostasis. In this review, we will focus on the mechanisms of transmembrane junction protein cleavage and their physiological, pathological and biological significance.</p></sec><sec><title>Extracellular Cleavage of Epithelial Transmembrane Junction Proteins</title><sec><title>Proteases that mediate extracellular cleavage of transmembrane junction proteins</title><p>In epithelial tissues, the extracellular domains of the transmembrane junction proteins are located along the lateral membrane in the paracellular space formed by between two adjacent cells. In the intercellular space, ectodomains of two neighboring cells form cell junctions. Thus, the ectodomains are exposed to several insults including extracellular proteases referred to as &#x0201c;sheddases.&#x0201d; Sheddases can cleave unprotected extracellular domains of the proteins in the paracellular space (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>). Such proteases include diverse proteins derived from the epithelium, endothelium, immune cells and bacteria. Many sheddases are misregulated in pathological states such as inflammation and cancer. In fact, one of the mechanisms by which cancer cells overcome cell adhesion to induce cell proliferation and metastasis is by upregulating the expression/activity of several sheddases that are capable of cleaving the extracellular domain of cell adhesion molecules.<xref ref-type="bibr" rid="R25"><sup>25</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R26"><sup>26</sup></xref> As shown in <xref ref-type="fig" rid="F2">Figure&#x000a0;2</xref>, cleavage of transmembrane proteins most often occurs at defined sites close to transmembrane regions of junction proteins. Interestingly, the extracellar cleavage products can modulate epithelial cellular processes such as cell-cell adhesion, cell migration and cell proliferation. In this review, we discuss proteases that generate cleavage products of junctional proteins which exert biological effects on epithelial homeostasis. Matrix metalloprotease (MMP), a disintegrin and metalloprotease (ADAM), &#x003b3;-secretase, serine proteases (kallikrein and plasmin) and bacterial proteases represent proteases that are involved in the cleavage of extracellular domain of junction proteins <bold>(</bold><xref ref-type="table" rid="T1">Table 1</xref> and <xref ref-type="fig" rid="F1">Figure&#x000a0;1</xref><bold>)</bold>. It is noteworthy to mention that &#x003b3;-secretase also functions as an intracellular protease for transmembrane junction proteins.<xref ref-type="bibr" rid="R27"><sup>27</sup></xref></p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><caption><p><bold>Figure&#x000a0;1.</bold> E-cadherin cleavage and its influence on epithelial homeostasis. This figure summarizes extracellular and intracellular cleavage of E-cadherin as detailed in the review.</p></caption><graphic xlink:href="tisb-1-e24783-g1"/></fig><fig id="F2" fig-type="figure" orientation="portrait" position="float"><caption><p><bold>Figure&#x000a0;2.</bold> Potential cleavage sites in transmembrane junctional proteins. These figures demonstrate potential cleavage sites of representative transmembrane junctional proteins in epithelial cells. <bold>(A)</bold> Tight junction proteins; <bold>(B)</bold> E-cadherin; <bold>(C)</bold> desmoglein</p></caption><graphic xlink:href="tisb-1-e24783-g2"/></fig><table-wrap id="T1" orientation="portrait" position="float"><caption><title><bold>Table&#x000a0;1.</bold> Extracellular cleavage of transmembrane junction proteins in epithelial cells</title></caption><table frame="hsides" rules="groups"><colgroup><col width="10.89%"/><col width="9.73%"/><col width="13.02%"/><col width="19.59%"/><col width="23.78%"/><col width="14.78%"/><col width="8.21%"/></colgroup><thead><tr><th align="center" valign="top">Junction protein</th><th colspan="2" align="center" valign="top">Protease</th><th align="center" valign="top">Model epithelial cell line</th><th align="center" valign="top">Functional output of cleavage product</th><th align="center" valign="top">Stimulus</th><th align="center" valign="top">Reference</th></tr></thead><tbody><tr><td align="center" valign="top"><bold>Claudin-2</bold><hr/></td><td align="center" valign="top"><bold>Serine protease</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>T84 (Colon)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="top"><bold>IFN-&#x003b3;</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R29">
<bold>29</bold>
</xref><hr/></td></tr><tr><td align="center" valign="top"><bold>EpCAM</bold><hr/></td><td align="center" valign="top"><bold>ADAM17 (TACE)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HEK293 (Kidney), FaDu (Hypopharynx)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R93">
<bold>93</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>&#x003b3;-secretase</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HEK293 (Kidney), HT29 (Colon)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R124">
<bold>124</bold>
</xref><hr/></td></tr><tr><td align="center" valign="top"><bold>JAM-A</bold><hr/></td><td align="center" valign="top"><bold>ADAM10, 17 (TACE)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HEK293 (Kidney)</bold><hr/></td><td align="center" valign="top"><bold>Neutrophil transmigration&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>PMA</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R35">
<bold>35</bold>
</xref><hr/></td></tr><tr><td align="center" valign="top"><bold>Occludin</bold><hr/></td><td align="center" valign="top"><bold>MMP</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MDCK (Kidney)</bold><hr/></td><td align="center" valign="top"><bold>Barrier function&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>Methyl-&#x003b2;-cyclodextrin</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R125">
<bold>125</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MMP2</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Primary human ectocervical epithelial cells, CaSki (Cervix)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R126">
<bold>126</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MMP7</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Primary human normal vaginal-cervical epithelial cells</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Estrogen</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R127">
<bold>127</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MMP9</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Human corneal epithelial cells, MMP9 knockout mouse</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R66">
<bold>66</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Human corneal epithelial cells</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Extracellular matrix metalloprotease inducer</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R28">
<bold>28</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Serine protease</bold><hr/></td><td align="center" valign="top"><bold>Plasmin</bold><hr/></td><td align="center" valign="top"><bold>Primary human ectocervical epithelial cells, CaSki (Cervix)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R126">
<bold>126</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Bacterial protease</bold><hr/></td><td align="center" valign="top"><bold>Aerolysin</bold><hr/></td><td align="center" valign="top"><bold>HT29/B6 (Colon)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R32">
<bold>32</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Haemagglutinin/ protease</bold><hr/></td><td align="center" valign="top"><bold>MDCK (Kidney)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R31">
<bold>31</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Protease K</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Primary human ectocervical epithelial cells, CaSki (Cervix)</bold><hr/></td><td align="center" valign="top"><bold>Barrier function&#x02193;</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R126">
<bold>126</bold>
</xref><hr/></td></tr><tr><td align="center" valign="top"><bold>E-cadherin</bold><hr/></td><td align="center" valign="top"><bold>MMP</bold><hr/></td><td align="center" valign="top"><bold>Membrane-bound</bold><hr/></td><td align="center" valign="top"><bold>SW480, HT29 (Colon), A431 (Skin), TE12, TE13 (Esophagus)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Mechanical scraping, ionomycin</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R84">
<bold>84</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MMP2</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>LNCapFGC (Prostate)</bold><hr/></td><td align="center" valign="top"><bold>Cell proliferation&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>PKD1</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R128">
<bold>128</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MMP3</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MDCK (Kidney), DU145 (Breast)</bold><hr/></td><td align="center" valign="top"><bold>Cell invasion&#x02191;, cell-cell adhesion&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>PMA</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R40">
<bold>40</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>SCp2, SCg6 (Breast)</bold><hr/></td><td align="center" valign="top"><bold>Cell-cell adhesion&#x02193;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R73">
<bold>73</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HC11 (Breast)</bold><hr/></td><td align="center" valign="top"><bold>Cell invasion&#x02191;</bold><hr/></td><td align="center" valign="top"><bold>FK506-binding domain dimerizer (AP20187)</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R74">
<bold>74</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MMP7</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MDCK (Kidney)</bold><hr/></td><td align="center" valign="top"><bold>Cell-cell adhesion&#x02193;, cell migration&#x02191;, cell polarization&#x02193;, cell proliferation&#x02191;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R129">
<bold>129</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MDCK (Kidney), MCF-7 (Breast)</bold><hr/></td><td align="center" valign="top"><bold>Cell invasion&#x02191;, cell-cell adhesion&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>PMA</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R40">
<bold>40</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>LNCaP-FGC (Prostate)</bold><hr/></td><td align="center" valign="top"><bold>Cell-cell adhesion&#x02193;, cell invasion&#x02191;</bold><hr/></td><td align="center" valign="top"><bold>HGF/SF</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R39">
<bold>39</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>A549 (Lung)</bold><hr/></td><td align="center" valign="top"><bold>Cell migration&#x02191;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R130">
<bold>130</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>NUGC-3, MKN-28 (Stomach)</bold><hr/></td><td align="center" valign="top"><bold>Cell invasion&#x02191;</bold><hr/></td><td align="center" valign="top"><bold>HGF</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R131">
<bold>131</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MMP9</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>OVCA433 (Ovary)</bold><hr/></td><td align="center" valign="top"><bold>Barrier function&#x02193;, cell-cell adhesion&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>Bead-immobilized &#x003b1;<sub>3</sub> or &#x003b2;<sub>1</sub> integrin antibody</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R41">
<bold>41</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MDCK (Kidney), DU145 (Breast)</bold><hr/></td><td align="center" valign="top"><bold>Cell proliferation&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>PKD1</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R128">
<bold>128</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>SCC10A (Head and neck)</bold><hr/></td><td align="center" valign="top"><bold>Cell migration&#x02191;, cell invasion&#x02191;</bold><hr/></td><td align="center" valign="top"><bold>EGF</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R132">
<bold>132</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Meprin&#x000df;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MDCK (Kidney), Caco-2 (Colon)</bold><hr/></td><td align="center" valign="top"><bold>Cell-cell adhesion&#x02193;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R133">
<bold>133</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>ADAM10</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HaCaT (Skin)</bold><hr/></td><td align="center" valign="top"><bold>Cell migration&#x02191;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R43">
<bold>43</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Primary human keratinocyte cells</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>TGF-&#x003b2;, IL-1&#x003b2;, LPS, IFN-&#x003b3; + TNF-&#x003b1;</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R134">
<bold>134</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>NCI-N87 (Stomach)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="top"><bold><italic>Helicobacter pylori</italic></bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R135">
<bold>135</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MDCK (Kidney)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Ephrin-B1</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R136">
<bold>136</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>ADAM15</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>SKBr3 (Breast)</bold><hr/></td><td align="center" valign="top"><bold>Cell prolieration&#x02191;, cell migration&#x02191;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R77">
<bold>77</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>&#x003b3;-secretase</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Caco-2 (Colon)</bold><hr/></td><td align="left" valign="top"><bold>Barrier function&#x02193;</bold><hr/></td><td align="left" valign="top"><bold><italic>Candida albicans</italic></bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R137">
<bold>137</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Serine protease</bold><hr/></td><td align="center" valign="top"><bold>Kallikrein 6</bold><hr/></td><td align="center" valign="top"><bold>HEK293 (Kidney)</bold><hr/></td><td align="left" valign="top"><bold>Cell-cell adhesion&#x02193;</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R138">
<bold>138</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Kallikrein 7</bold><hr/></td><td align="center" valign="top"><bold>BxPC-3 (Pancreas)</bold><hr/></td><td align="left" valign="top"><bold>Cell invasion&#x02191;, cell-cell adhesion&#x02193;</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R63">
<bold>63</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Plasmin</bold><hr/></td><td align="center" valign="top"><bold>MDCK (Kidney)</bold><hr/></td><td align="left" valign="top"><bold>Cell-cell adhesion&#x02193;, cell invasion&#x02191;</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R62">
<bold>62</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>OVCA429 (Ovary)</bold><hr/></td><td align="left" valign="top"><bold>Cell invasion&#x02191;</bold><hr/></td><td align="left" valign="top"><bold>LPA</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R115">
<bold>115</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Bacterial protease</bold><hr/></td><td align="center" valign="top"><bold>Fragilysin</bold><hr/></td><td align="center" valign="top"><bold>HT29/C1 (Colon)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R45">
<bold>45</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Gingipain</bold><hr/></td><td align="center" valign="top"><bold>MDCK (Kidney)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R46">
<bold>46</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HtrA</bold><hr/></td><td align="center" valign="top"><bold>MKN-28 (Stomach)</bold><hr/></td><td align="left" valign="top"><bold>Bacteria invasion&#x02191;, bacterial transmigration&#x02191;</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R44">
<bold>44</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Leukocyte elastase</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Rat pancreatic tissue, primary rat pancreatic acinar cells</bold><hr/></td><td align="left" valign="top"><bold>Leukocyte transmigration&#x02191;, cell-cell adhesion&#x02193;</bold><hr/></td><td align="left" valign="top"><bold>Cerulein</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R139">
<bold>139</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Cysteine protease</bold><hr/></td><td align="center" valign="top"><bold>Cathepsins: B, S, L</bold><hr/></td><td align="center" valign="top"><bold>Mouse pancreatic cancer model</bold><hr/></td><td align="left" valign="top"><bold>Cell invasion&#x02191;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R140">
<bold>140</bold>
</xref><hr/></td></tr><tr><td align="center" valign="top"><bold>Nectin-1&#x003b1;</bold><hr/></td><td align="center" valign="top"><bold>MMP</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MDCK (Kidney)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><bold>TPA, HGF/SF</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R48">
<bold>48</bold>
</xref><hr/></td></tr><tr><td align="center" valign="top"><bold>Nectin-4</bold><hr/></td><td align="center" valign="top"><bold>ADAM17 (TACE)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>CHO (Ovary), T47D (Breast)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><bold>PMA</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R49">
<bold>49</bold>
</xref><hr/></td></tr><tr><td align="center" valign="top"><bold>Desmoglein 1</bold><hr/></td><td align="center" valign="top"><bold>MMP</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>A431 (Skin)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><bold>UV </bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R141">
<bold>141</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Serine protease</bold><hr/></td><td align="center" valign="top"><bold>Plasmin</bold><hr/></td><td align="center" valign="top"><bold>Human skin tissue</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R142">
<bold>142</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Exfoliative toxin A</bold><hr/></td><td align="center" valign="top"><bold>Mouse skin</bold><hr/></td><td align="left" valign="top"><bold>Cell-cell adhesion&#x02193;</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R53">
<bold>53</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HaCaT (Skin)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R54">
<bold>54</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Organotypic raft model of human epidermis, primary human epidermal keratinocytes</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R50">
<bold>50</bold>
</xref><bold>,</bold><xref ref-type="bibr" rid="R52">
<bold>52</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Kallikrein 5</bold><hr/></td><td align="center" valign="top"><bold>SCC25 (Tongue)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R51">
<bold>51</bold>
</xref><hr/></td></tr><tr><td align="center" valign="top"><bold>Desmoglein 2</bold><hr/></td><td align="center" valign="top"><bold>MMP</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>SKCO-15 (Colon)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R86">
<bold>86</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>ADAM10</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>CHO (Ovary), A431 (Skin), ADAM10 knockout mouse</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><bold>EGF</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R58">
<bold>58</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>ADAM17 (TACE)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>SCC68 (Skin)</bold><hr/></td><td align="left" valign="top"><bold>Cell-cell adhesion&#x02193;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R143">
<bold>143</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>CHO (Ovary), A431 (Skin), ADAM10 knockout mouse</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><bold>EGF</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R58">
<bold>58</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>A431 (Skin)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R144">
<bold>144</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Serine protease</bold><hr/></td><td align="center" valign="top"><bold>Kallikrein 7</bold><hr/></td><td align="center" valign="top"><bold>Panc-1, BxPC-3 (Pancreas)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R145">
<bold>145</bold>
</xref><hr/></td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Matriptase</bold><hr/></td><td align="center" valign="top"><bold>HCT-116 (Colon)</bold><hr/></td><td align="center" valign="top"><bold>Cell-cell adhesion&#x02193;</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R57">
<bold>57</bold>
</xref><hr/></td></tr><tr><td align="center" valign="top"><bold>Desmoglein 3</bold><hr/></td><td align="center" valign="top"><bold>MMP</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HaCaT (Skin)</bold><hr/></td><td align="left" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Staurosporine </bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R146">
<bold>146</bold>
</xref><hr/></td></tr><tr><td align="center" valign="top"><bold>Desmocollin 3</bold></td><td align="left" valign="top">&#x000a0;</td><td align="left" valign="top">&#x000a0;</td><td align="left" valign="top">&#x000a0;</td><td align="left" valign="bottom">&#x000a0;</td><td align="left" valign="bottom">&#x000a0;</td><td align="left" valign="bottom">&#x000a0;</td></tr></tbody></table></table-wrap><sec><title>Tight junction</title><p>Given the role of TJs as gatekeepers, cleavage of transmembrane proteins that form these structures is often associated with epithelial barrier breakdown. However, despite their importance in controlling epithelial barrier function, extracellular cleavage of integral proteins in TJs during physiological and pathological conditions is not well characterized. Huet et al. have reported that the induction of MMP9 by the extracellular matrix metalloprotease inducer (EMMPRIN; also termed CD147) results in cleavage of occludin extracellular domain and disruption of barrier function associated with pathogenesis of dry eye disease.<xref ref-type="bibr" rid="R28"><sup>28</sup></xref> Willemsen et al. have also shown that interferon<italic>-</italic>gamma (IFN&#x003b3;) activates cellular serine proteases that cleave claudin-2 extracellular domain.<xref ref-type="bibr" rid="R29"><sup>29</sup></xref> Occludin has also been shown to be cleaved by several bacterial proteases including the cysteine protease Der p 1 from house dust mite,<xref ref-type="bibr" rid="R30"><sup>30</sup></xref> haemagglutinin/protease (metalloprotease) from <italic>Vibrio Cholerae</italic>,<xref ref-type="bibr" rid="R31"><sup>31</sup></xref> and secreted pore-forming toxin aerolysin produced by <italic>Aeromonas hydrophila</italic>.<xref ref-type="bibr" rid="R32"><sup>32</sup></xref> Paracellular barrier compromise by haemagglutinin/protease and aerolysin has been linked to clinical diarrhea. Epithelial barrier disruption by house dust mite and pollen extract contributes to allergic diseases such as asthma.<xref ref-type="bibr" rid="R30"><sup>30</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R33"><sup>33</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R34"><sup>34</sup></xref> Koenen et al. reported that cleavage and shedding of the TJ protein, JAM-A is mediated by ADAM17 and 10 during inflammation resulting in inhibition of neutrophil transendothelial diapedesis.<xref ref-type="bibr" rid="R35"><sup>35</sup></xref> These findings highlight cleavage of transmembrane TJ proteins is essential mechanism that mediates disruption of epithelial barriers.</p></sec><sec><title>Adherens junction</title><p>The AJ intercellular space (~200 &#x000c5;)<xref ref-type="bibr" rid="R1"><sup>1</sup></xref> contains extracellular domains of classical-cadherin family members and nectins, which constitute the two major family of integral membrane proteins in this region. Nectins and cadherins control several physiological processes including cell-cell adhesion, cell signaling, proliferation and differentiation.<xref ref-type="bibr" rid="R36"><sup>36</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R38"><sup>38</sup></xref> For example, soluble E-cadherin (sE-cadherin) fragment resulting from cleavage of the E-cadherin extracellular domain by MMPs<xref ref-type="bibr" rid="R39"><sup>39</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R41"><sup>41</sup></xref> can function as a paracrine/autocrine signal to prevent cell death by activating epidermal growth factor receptor (EGFR) signaling and inhibiting apoptosis.<xref ref-type="bibr" rid="R42"><sup>42</sup></xref> Shedding of sE-cadherin fragment has also been reported for other cellular proteases such as ADAMs<xref ref-type="bibr" rid="R43"><sup>43</sup></xref> and &#x003b3;-secretase.<xref ref-type="bibr" rid="R27"><sup>27</sup></xref> In addition to cellular proteases, the extracellular domain of E-cadherin is targeted by several bacterial proteases that include HtrA protease from <italic>Helicobacter pylori</italic>,<xref ref-type="bibr" rid="R44"><sup>44</sup></xref> fragilysin from <italic>Bacteroides fragilis</italic><xref ref-type="bibr" rid="R45"><sup>45</sup></xref> and the gingipains from <italic>Porphyromonas gingivali</italic>.<xref ref-type="bibr" rid="R46"><sup>46</sup></xref> These bacterial proteases influence epithelial homeostasis analogous to cellular proteases. In addition to E-cadherin, other integral membrane AJ proteins such as the nectin-1 ectodomain are cleaved in neurons by MMPs.<xref ref-type="bibr" rid="R47"><sup>47</sup></xref> The entire ectodomain of nectin-4 and nectin-1&#x003b1; are shed by MMPs in cancer and during cell spreading.<xref ref-type="bibr" rid="R48"><sup>48</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R49"><sup>49</sup></xref> The stability of these fragments in different body fluids suggests a putative role of these ectodomains as mediators of diverse biological processes.</p></sec><sec><title>Desmosome</title><p>Analogous to E-cadherin, desmosomal cadherins including Dsg and Dsc family members undergo extracellular domain cleavage during inflammation and cancer.<xref ref-type="bibr" rid="R18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R50"><sup>50</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R51"><sup>51</sup></xref> Indeed, extracellular domain cleavage of desmosomal cadherins has been reported to influence epithelial homeostasis.<xref ref-type="bibr" rid="R18"><sup>18</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R51"><sup>51</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R52"><sup>52</sup></xref> In keratinocytes, where desmosomal cadherins are the major adhesion molecules, cleavage of desmosomal cadherins contributes to pathogenesis of diseases. For instance, the staphylococcal exfoliative toxin, which is causative agent of bullous impetigo and staphylococcal scalded skin syndrome have been shown to specifically target the ectodomain of Dsg1.<xref ref-type="bibr" rid="R53"><sup>53</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R54"><sup>54</sup></xref> In Netherton syndrome, which is an autosomal skin disease characterized by skin inflammation and scaling, Dsg1 cleavage occurs as a consequence of kallikrein hyperactivation due to the inactivation of the serine protease inhibitor of kazal type 5 (SPINK5).<xref ref-type="bibr" rid="R55"><sup>55</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R56"><sup>56</sup></xref> Additionally, shedding of desmosomal cadherin ectodomains by cellular proteases has been reported during cancer progression and metastasis implying a role of these molecules in modulating invasion and metastasis. For example, cleavage of Dsg2 in intestinal epithelial cells by matriptase has been associated with decreased cancer cell-cell adhesion.<xref ref-type="bibr" rid="R57"><sup>57</sup></xref> ADAM17 and 10 have also been implicated in the shedding of Dsg2 during cancer development.<xref ref-type="bibr" rid="R58"><sup>58</sup></xref> A similar mechanism has been described in the pathogenesis of oral squamous cell carcinoma where cleavage of Dsg1 by kallikrein 5 is necessary to reduce cell-cell adhesion in order to enhance cell migration.<xref ref-type="bibr" rid="R51"><sup>51</sup></xref> Thus, understanding the mechanisms that regulate desmosomal cadherin cleavage is important in understanding the pathogenesis of several diseases.</p></sec></sec><sec><title>Biological effects of epithelial junction protein extracellular cleavage fragments</title><p>Recent evidence suggests that cleavage fragment of junctional proteins possess different biological activities.<xref ref-type="bibr" rid="R26"><sup>26</sup></xref> These fragment not only control normal homeostatic event in the epithelia such as cell proliferation, migration and apoptosis but also contribute to pathogenesis of mucosal inflammation and cancer. In this section, we describe the biological effects of soluble intercellular junction protein cleavage fragments.</p><sec><title>Cell-cell adhesion</title><p>Cell-cell adhesion in epithelial cells is mediated by AJ and desmosomal proteins. It&#x02019;s well known that disruption of cell-cell adhesion contributes to metastasis of cancer cells. Several reports have shown that extracellular cleavage of intercellular junction proteins results in loss of cell-cell adhesion.<xref ref-type="bibr" rid="R59"><sup>59</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R60"><sup>60</sup></xref> Moreover, recent findings have also shown that soluble extracellular cleavage products of intercellular junction proteins can regulate epithelial cell-cell adhesion by paracrine or autocrine signaling. Wheelock et al. reported that the 80 kd sE-cadherin fragment disrupts cell-cell adhesion in a human mammary carcinoma cell line.<xref ref-type="bibr" rid="R61"><sup>61</sup></xref> Symowicz et al. have also demonstrated that recombinant sE-cadherin promotes cell junction disruption and metastasis of ovarian carcinoma cells.<xref ref-type="bibr" rid="R41"><sup>41</sup></xref> Additionally, extracellular E-cadherin fragments released by serine proteases, plasmin and kallikrein 7 inhibit cellular aggregation.<xref ref-type="bibr" rid="R62"><sup>62</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R63"><sup>63</sup></xref> These findings suggest that extracellular E-cadherin fragments have functional effects that inhibit endogenous cell-cell junction protein function. However, it still remains unknown how these cleavage products interact with cell-cell junction proteins and whether or not extracellular cleavage products of other intercellular junction proteins such as nectins or desmosomal cadherins have similar biological effects on cell-cell adhesion.</p></sec><sec><title>Barrier function</title><p>Epithelial tissues provide physical and permeability barriers in vertebrates. In simple epithelium the barrier is formed by epithelial cells where the paracellular space is sealed by intercellular contacts. MMPs actively participate in the disruption of epithelial barrier under several conditions. For example, during inflammation, proinflammatory cytokines released in the milieu of ocular epithelium enhance MMP9 expression and activation that promotes cleavage of the TJ protein occludin thereby resulting in increased corneal epithelial permeability.<xref ref-type="bibr" rid="R28"><sup>28</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R64"><sup>64</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R66"><sup>66</sup></xref> Of interest MMP9 expression and activity has been directly linked to dry eyes in human patients with ocular rosacea and rheumatoid arthritis.<xref ref-type="bibr" rid="R64"><sup>64</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R65"><sup>65</sup></xref> Moreover, virulence factors can also perturb epithelial barrier function by inducing cleavage of specific transmembrane epithelial junction proteins. The effects of these bacterial proteases are broad in range and some are very well characterized. Fragilysin from <italic>Bacteroides fragilis</italic> cleaves the extracellular domain of E-cadherin to disrupt barrier function.<xref ref-type="bibr" rid="R45"><sup>45</sup></xref> In contrast, the zinc-containing metalloprotease from <italic>Vibrio cholerae</italic> decreases epithelial barrier function by targeting the extracellular domain of occludin.<xref ref-type="bibr" rid="R31"><sup>31</sup></xref> In addition to its role in compromising the epithelial barrier, mimetic peptides of transmembrane junction proteins and virus-derived proteins can transiently modulate epithelial barrier function. Interestingly, the efficiency and reliability of this system has been used in recent years to transiently compromise the paracellular pathway in order to promote drug delivery across the epithelium.<xref ref-type="bibr" rid="R67"><sup>67</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R71"><sup>71</sup></xref></p></sec><sec><title>Migration and invasion</title><p>Epithelial cells are less mobile than most other cell types. Disruption of cell adhesion to enhance cell migration and invasion is an integral event in cancer metastasis.<xref ref-type="bibr" rid="R72"><sup>72</sup></xref> As mentioned above, cleavage of transmembrane junction proteins by proteases reduces cell-cell adhesion and directly enhances cell migration and invasion.<xref ref-type="bibr" rid="R59"><sup>59</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R60"><sup>60</sup></xref> Interestingly, it has been shown that the extracellular cleavage products from intercellular junction proteins can also induce cell migration and invasion. The role of sE-cadherin in cell migration and invasion is well known.<xref ref-type="bibr" rid="R40"><sup>40</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R62"><sup>62</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R73"><sup>73</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R74"><sup>74</sup></xref> Most recently, Brouxhon et al. have demonstrated that sE-cadherin promotes cell migration and tumor invasion by activating MMP2 and 9 in murine skin squamous carcinoma cell lines.<xref ref-type="bibr" rid="R75"><sup>75</sup></xref> Furthermore, in human lung tumor cells, the presence of sE-cadherin in conditioned media and E-cadherin HAV peptides simulating E-cadherin EC1 domain induce MMP2, 9 and MT1-MMP transcription and activation resulting in cell invasion.<xref ref-type="bibr" rid="R76"><sup>76</sup></xref> Taken together, these findings suggest that sE-cadherin has functional properties that promote cell migration and invasion by inducing MMP activity. Increased junction protein cleavage, reported in inflammation, exerts biological effects on mucosal homeostasis. Soluble JAM-A ectodomain fragments have been reported to modulate endothelial cell migration and prevent neutrophil extravasation.<xref ref-type="bibr" rid="R35"><sup>35</sup></xref> However, mechanisms by which soluble extracellular junction protein cleavage fragments modulate cell migration are complex and not well understood.</p></sec><sec><title>Cell proliferation and apoptosis</title><p>Several reports have linked junction extracellular cleavage products to cell proliferation and apoptosis.<xref ref-type="bibr" rid="R42"><sup>42</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R59"><sup>59</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R75"><sup>75</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R77"><sup>77</sup></xref> These studies have also highlighted underlying signaling pathways that mediate the biological effect of junction protein cleavage fragments. In skin cancer cells, exogenous sE-cadherin can interact with EGFR and human epidermal growth factor receptor (HER) 2 to activate them and their downstream singnaling proteins: phosphoinositide-3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) and mitogen-activated protein kinase (MAPK). Ultimately, the cleavage fragments induce cell proliferation.<xref ref-type="bibr" rid="R75"><sup>75</sup></xref> Najy et al. have also shown the interaction between exogenous sE-cadherin and HER2-HER3 heterodimer in breast cancer cells where sE-cadherin promotes cell proliferation via HER2-HER3 and extracellular signal-regulated kinase (ERK) activation.<xref ref-type="bibr" rid="R77"><sup>77</sup></xref> In addition to proliferation, recent evidence indicates that extracellular cleavage products can regulate cell survival. For example, Inge et al. have revealed that sE-cadherin can suppress apoptosis thereby promote cell survival and these effects are mediated by activation of EGFR signaling via PI3K/Akt and ERK1/2.<xref ref-type="bibr" rid="R42"><sup>42</sup></xref> However, cleavage or loss of the transmembrane proteins in cell junctions has also been linked to the presence or appearance of pro-apoptotic signals.<xref ref-type="bibr" rid="R78"><sup>78</sup></xref> In fact, metalloprotease cleavage of desmosomal cadherins during keratinocyte apoptosis has been reported.<xref ref-type="bibr" rid="R79"><sup>79</sup></xref> Additionally, and in simple epithelium, cleavage of E-cadherin by sheddasses is an essential step in the onset of apoptosis.<xref ref-type="bibr" rid="R80"><sup>80</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R81"><sup>81</sup></xref></p></sec></sec></sec><sec><title>Intracellular Cleavage of Epithelial Transmembrane Junction Proteins</title><sec><title>Proteases that mediate intracellular cleavage of junction proteins</title><p>Transmembrane junction proteins associate with an underlying actin cytoskeleton via scaffold proteins that constrains their intracellular domains. Intracellular domains can also be targeted by proteases that are in the vicinity of the cytoplasmic surface of the plasmamembrane.</p><p>Several proteases that are activated during inflammation and cancer mediate intracellular cleavage of cell-cell junction proteins. Additionally, increased expression/activity of proteases that cleave adhesion proteins facilitates cancer cell proliferation and metastasis.<xref ref-type="bibr" rid="R25"><sup>25</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R26"><sup>26</sup></xref> Interestingly, following extracellular domain shedding, the membrane-associated proteins undergo proteolytic processing thereby generating soluble intracellular fragments that exert biological effects. Cleavage of such protein fragments is mediated by intracellular and membrane associated proteases such as calpain, caspase, cathepsin and &#x003b3;-secretase.<xref ref-type="bibr" rid="R27"><sup>27</sup></xref> Intracellular proteases promote intracellular cleavage of junction proteins that in turn induces cytoskeletal restructuring as well as modification in scaffold and signaling proteins to maintain epithelial homeostasis (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>). Recent reports have highlighted biological effects of intracellular cleavage fragments of junction proteins <bold>(</bold><xref ref-type="table" rid="T2"><bold>Table 2</bold></xref><bold>)</bold>.</p><table-wrap id="T2" orientation="portrait" position="float"><caption><title><bold>Table&#x000a0;2.</bold> Intracellular cleavage of transmembrane junction protein in epithelial cells</title></caption><table frame="hsides" rules="groups"><colgroup><col width="10.52%"/><col width="8.12%"/><col width="9.11%"/><col width="17.43%"/><col width="19.28%"/><col width="21.12%"/><col width="6.92%"/><col width="7.5%"/></colgroup><thead><tr><th align="center" valign="top">Junction protein</th><th colspan="2" align="center" valign="top">Protease</th><th align="center" valign="top">Model epithelial cell line</th><th align="center" valign="top">Functional output of cleavage product</th><th align="center" valign="top">Stimulus</th><th align="center" valign="top">Reference</th><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr></thead><tbody><tr><td align="center" valign="top"><bold>Claudin-2</bold><hr/></td><td colspan="2" align="center" valign="top"><bold>Serine protease</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>T84 (Colon)</bold><hr/></td><td align="center" valign="bottom"><bold>IFN&#x003b3;</bold><hr/></td><td align="center" valign="top"><xref ref-type="bibr" rid="R29">
<bold>29</bold>
</xref><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td></tr><tr><td align="center" valign="top"><bold>EpCAM</bold><hr/></td><td align="center" valign="top"><bold>&#x003b3;-secretase</bold><hr/></td><td align="center" valign="top"><bold>Presenilin 2</bold><hr/></td><td align="center" valign="top"><bold>HEK293 (Kidney)</bold><hr/></td><td align="center" valign="top"><bold>Cell proliferation&#x02191;</bold><hr/></td><td align="center" valign="top"><bold>Extracellular cleavage product of EpCAM</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R93">
<bold>93</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HEK293 (Kidney), HT29 (Colon)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R124">
<bold>124</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="center" valign="top"><bold>Occludin</bold><hr/></td><td align="center" valign="top"><bold>MMP</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MDCK (Kidney)</bold><hr/></td><td align="center" valign="top"><bold>Barrier function&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>Methyl-&#x003b2;-cyclodextrin</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R125">
<bold>125</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Cysteine protease</bold><hr/></td><td align="center" valign="top"><bold>Calpain</bold><hr/></td><td align="center" valign="top"><bold>Caco-2 (Colon), HaCaT (Skin)</bold><hr/></td><td align="center" valign="top"><bold>Barrier function&#x02193;, bacterial translocation</bold><hr/></td><td align="center" valign="top"><bold>Streptolysin S</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R82">
<bold>82</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>16 HBE, 1HAEo (Lung/Bronchus)</bold><hr/></td><td align="center" valign="top"><bold>Polymorphonuclear leukocytes (PMNs) transmigration</bold><hr/></td><td align="center" valign="top"><bold>Toll-like receptor 2 ligands</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R83">
<bold>83</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Der p 1</bold><hr/></td><td align="center" valign="top"><bold>MDCK (Kidney), 16HBE14o (Lung/Bronchus)</bold><hr/></td><td align="center" valign="top"><bold>Barrier function&#x02193;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R30">
<bold>30</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="center" valign="top"><bold>E-cadherin</bold><hr/></td><td align="center" valign="top"><bold>MMP7</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MDCK (Kidney)</bold><hr/></td><td align="center" valign="top"><bold>Cell-cell adhesion&#x02193;, cell migration&#x02191;, cell polarization&#x02193;, cell proliferation&#x02191;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R129">
<bold>129</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MMP</bold><hr/></td><td align="center" valign="top"><bold>Membrane-bound</bold><hr/></td><td align="center" valign="top"><bold>SW480, HT29 (Colon), A431 (Skin), TH12, TE13 (Esophagus)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Mechanical scraping, ionomycin</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R84">
<bold>84</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>MT1-MMP (MMP14)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>NRK-52E (Kidney)</bold><hr/></td><td align="center" valign="top"><bold>Cell-cell adhesion&#x02193;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R147">
<bold>147</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>ADAM10</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Primary human keratinocyte cells</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>TGF&#x003b2;, IL-1&#x003b2;, LPS, IFN&#x003b3; + TNF&#x003b1;</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R134">
<bold>134</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>&#x003b3;-secretase</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Caco-2 (Colon)</bold><hr/></td><td align="center" valign="top"><bold>Barrier function&#x02193;</bold><hr/></td><td align="center" valign="top"><bold><italic>Candida albicans</italic></bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R137">
<bold>137</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>T47D, MCF-7 (Breast)</bold><hr/></td><td align="center" valign="top"><bold>Cell-cell adhesion&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>Staurosporine </bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R148">
<bold>148</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>A431 (Skin), MCF-7 (Breast), MDCK (Kidney)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R91">
<bold>91</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Presenilin 1</bold><hr/></td><td align="center" valign="top"><bold>Murine embryonic fibroblast, SW480 (Colon)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R90">
<bold>90</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>A431 (Skin)</bold><hr/></td><td align="center" valign="top"><bold>Cell-cell adhesion&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>Ionomycin</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R27">
<bold>27</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Caspase</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HER313A (Retina)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R149">
<bold>149</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Caspase-3</bold><hr/></td><td align="center" valign="top"><bold>H184A1 (Breast)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Staurosporine </bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R80">
<bold>80</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Cysteine protease</bold><hr/></td><td align="center" valign="top"><bold>Calpain</bold><hr/></td><td align="center" valign="top"><bold>LNCaP (Prostate), MCF-7, SKBR3 (Breast)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>TPA, ionomycin</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R23">
<bold>23</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>16 HBE, 1HAEo (Lung/Bronchus)</bold><hr/></td><td align="center" valign="top"><bold>PMNs transmigration</bold><hr/></td><td align="center" valign="top"><bold>Toll-like receptor 2 ligands</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R83">
<bold>83</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Caco-2 (Colon), HaCaT (Skin)</bold><hr/></td><td align="center" valign="top"><bold>Barrier function&#x02193;, bacterial translocation</bold><hr/></td><td align="center" valign="top"><bold>Streptolysin S</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R82">
<bold>82</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Cathepsins (B, S, L)</bold><hr/></td><td align="center" valign="top"><bold>Mouse pancreatic cancer model</bold><hr/></td><td align="center" valign="top"><bold>Cell invasion&#x02191;</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R140">
<bold>140</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="center" valign="top"><bold>Nectin-1&#x003b1;</bold><hr/></td><td align="center" valign="top"><bold>&#x003b3;-secretase</bold><hr/></td><td align="center" valign="top"><bold>Presenilin 1</bold><hr/></td><td align="center" valign="top"><bold>CHO (Ovary)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>TPA</bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R150">
<bold>150</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="center" valign="top"><bold>Desmoglein 1</bold><hr/></td><td align="center" valign="top"><bold>Caspase</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>HaCaT (Skin)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Staurosporine </bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R79">
<bold>79</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Caspase-3</bold><hr/></td><td align="center" valign="top"><bold>A431 (Skin)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>UV </bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R141">
<bold>141</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="center" valign="top"><bold>Desmoglein 2</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>T84 (Colon)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Camptothecin </bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R14">
<bold>14</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Caspase-3</bold><hr/></td><td align="center" valign="top"><bold>HaCaT cells (Skin), HT29 (Colon)</bold><hr/></td><td align="center" valign="top"><bold>Cell-cell adhesion&#x02193;</bold><hr/></td><td align="center" valign="top"><bold>Staurosporine </bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R85">
<bold>85</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Cysteine protease</bold><hr/></td><td align="center" valign="top"><bold>Calpain</bold><hr/></td><td align="center" valign="top"><bold>T84 (Colon)</bold><hr/></td><td align="left" valign="top">&#x000a0;<hr/></td><td align="center" valign="top"><bold>Camptothecin </bold><hr/></td><td align="left" valign="top"><xref ref-type="bibr" rid="R14">
<bold>14</bold>
</xref><hr/></td><td style="border-bottom: 0.5pt solid ; ">&#x000a0;</td></tr><tr><td align="center" valign="top"><bold>Desmoglein 3</bold></td><td align="center" valign="top"><bold>Caspase</bold></td><td align="left" valign="top">&#x000a0;</td><td align="center" valign="top"><bold>HaCaT (Skin)</bold></td><td align="left" valign="top">&#x000a0;</td><td align="center" valign="top"><bold>Staurosporine </bold></td><td align="center" valign="top"><xref ref-type="bibr" rid="R146">
<bold>146</bold>
</xref></td><td style="">&#x000a0;</td></tr></tbody></table></table-wrap><sec><title>Tight junction</title><p>Little is known about the intracellular cleavage of TJ proteins. Sumitomo et al. have demonstrated that calpain activated by Streptolysin S from Group A <italic>streptococcus</italic>, cleaves occludin and disrupts barrier function of intestinal epithelial cells and keratinocytes.<xref ref-type="bibr" rid="R82"><sup>82</sup></xref> Willemsen et al. have also shown that cellular serine protease activated by IFN-&#x003b3; treatment can cleave intracellular domain of claudin-2.<xref ref-type="bibr" rid="R29"><sup>29</sup></xref> Additionally, toll-like receptor (TLR) 2-induced calpain cleaves intracellular domain of occludin and promotes polymorphonuclear leukocyte transmigration.<xref ref-type="bibr" rid="R83"><sup>83</sup></xref></p></sec><sec><title>Adherens junction</title><p>The intracellular fragment of E-cadherin that remains attached to the cellular membrane after cleavage by membrane-bound metalloproteases, generates a cytosolic fragment (33 kDa) when &#x003b3;-secretase is activated. The 33 kDa cytosolic fragment promotes intracellular signaling and cell proliferation.<xref ref-type="bibr" rid="R27"><sup>27</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R84"><sup>84</sup></xref> In addition to cleavage by membrane associated proteases, the cytosolic domain of E-cadherin has been shown to be further cleaved by intracellular proteases such as calpain.<xref ref-type="bibr" rid="R23"><sup>23</sup></xref> However, the fragments generated by calpain have been shown to induce apoptosis instead of proliferation in epithelial cells.<xref ref-type="bibr" rid="R81"><sup>81</sup></xref> Interestingly, it has also been proposed that during apoptosis the 33 kDa fragment generated by &#x003b3;-secretase is also targeted by caspase-3 to generate a 29 kDa fragment. However, the function of this cleavage fragment has not been characterized, but its localization and distribution suggest a putative role in the regulation of epithelial cell apoptosis.<xref ref-type="bibr" rid="R80"><sup>80</sup></xref> Thus, proteolysis of epithelial cadherin allows the formation of several intracellular fragments that have biological activities. Furthermore, E-cadherin intracellular fragments are important in activating signaling pathways that control physiological and pathological events.</p></sec><sec><title>Desmosome</title><p>In simple epithelium, cleavage of desmosomal cadherins by cysteine proteases has been shown to be an important step in the disassembly of the DMs.<xref ref-type="bibr" rid="R85"><sup>85</sup></xref> Desmosomal disassembly may directly contribute to the detachment of the dead cells observed in epithelial tissues. The cytosolic fragments generated by Dsg2 cleavage have been observed in human colon tissues.<xref ref-type="bibr" rid="R86"><sup>86</sup></xref> We have observed that an intracellular Dsg2 cleavage fragment promotes apoptosis in the intestinal epithelium.<xref ref-type="bibr" rid="R14"><sup>14</sup></xref> We have also reported a similar Dsg2 cleavage fragment in nasal polyps after cytokine exposure.<xref ref-type="bibr" rid="R87"><sup>87</sup></xref> However, in addition to apoptosis, we cannot rule out the possibility that the cytosolic fragments generated after Dsg2 cleavage serve to promote cell proliferation. In fact, Brennan et al. have demonstrated that Dsg2 proteolytic products are elevated in vivo in skin tumors from transgenic mice overexpressing Dsg2.<xref ref-type="bibr" rid="R88"><sup>88</sup></xref> These results suggest that the cytosolic fragment of Dsg2 may be responsible for the regulation of several mitogenic signaling pathways such as Akt, MAPK and the signal transducer and activator of transcription (STAT) 3.<xref ref-type="bibr" rid="R89"><sup>89</sup></xref></p></sec></sec><sec><title>Biological effects of junction protein intracellular cleavage products</title><p>As described above, several intracellular proteases including &#x003b3;-secretase, calpain and caspase are responsible for cleavage of intercellular junction proteins that in turn exert biological effects. We have previously observed that an intracellular Dsg2 cleavage fragment generated by serine proteases promotes apoptosis in intestinal epithelial cells.<xref ref-type="bibr" rid="R14"><sup>14</sup></xref> Some cleavage fragments can translocate to the nucleus to regulate transcriptional activity and cell survival. For instance, 35 kDa E-cadherin C-terminal fragment (CTF) generated by presenilin 1 regulates &#x003b2;-catenin/T cell factor (Tcf)-4 transcriptional activity.<xref ref-type="bibr" rid="R90"><sup>90</sup></xref> E-cadherin/CTF translocates to the nucleus to influence Kaiso-regulated gene transcription. Nuclear localization of E-cadherin/CTF is also enhanced by p120-catenin.<xref ref-type="bibr" rid="R91"><sup>91</sup></xref> Furthermore, presenilin 1 induces E-cadherin cytoplasmic cleavage, generating products that promote disassembly of E-cadherin-catenin complex by sequestering &#x003b2;-catenin in the cytosol.<xref ref-type="bibr" rid="R27"><sup>27</sup></xref> Additionally, calpain induced cleavage of intracellular E-cadherin domain generates a 100 kDa cleavage product that regulates cell survival in prostate epithelial cells.<xref ref-type="bibr" rid="R81"><sup>81</sup></xref> Similar to E-cadherin, presenillin promotes the release of the CTF in N-cadherin which also plays an important role in the regulation of &#x003b2;-catenin signaling.<xref ref-type="bibr" rid="R92"><sup>92</sup></xref></p><p>In addition to cadherins, intracellular domains of epithelial cell adhesion molecule (EpCAM) generated by presenilin 2 translocates to the nucleus with four and a half LIM-domain protein (FHL) 2 and &#x003b2;-catenin to promote lymphoid enhancer-binding factor (Lef)-1 transactivation and epithelial proliferation.<xref ref-type="bibr" rid="R93"><sup>93</sup></xref> Interestingly, truncated Dsg1 and 2 generated by extracellular domain cleavage can influence cell-surface desmosomal cadherins through the interaction of raft-associated protein, caveolin-1 and plakoglobin.<xref ref-type="bibr" rid="R50"><sup>50</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R88"><sup>88</sup></xref></p></sec></sec><sec><title>Signaling Pathways Triggered by Cleavage of Transmembrane Junction Proteins</title><p>Transmembrane junction proteins regulate cell proliferation, differentiation and apoptosis by controlling several signaling pathways. The mechanism by which the cleavage fragments regulate these processes is incompletely understood. Dimerization and autophosphorylation of receptor tyrosine kinases (RTKs) by the extracellular cleavage products of cadherin family members can regulate epithelial homeostasis. For example, sE-cadherin results in RTK ligand-independent dimerization, activation of the receptor and stimulation of several intracellular signaling pathways including MAPK, PI3K, Akt and mTOR.<xref ref-type="bibr" rid="R94"><sup>94</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R95"><sup>95</sup></xref> These signaling pathways influence biological events such as cell proliferation,<xref ref-type="bibr" rid="R94"><sup>94</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R95"><sup>95</sup></xref> growth,<xref ref-type="bibr" rid="R94"><sup>94</sup></xref> and cell migration.<xref ref-type="bibr" rid="R96"><sup>96</sup></xref> As a consequence of RTK interaction with sE-cadherin, activation of pro-proliferative and anti-apoptotic signaling pathways was observed. Thus, the presence of sE-cadherin in the serum has been associated with poor prognosis in cancer patients.<xref ref-type="bibr" rid="R77"><sup>77</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R97"><sup>97</sup></xref> However, given that shedding of the cadherin ectodomain has also been reported in physiological conditions or in other pathologies such as inflammation,<xref ref-type="bibr" rid="R50"><sup>50</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R52"><sup>52</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R54"><sup>54</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R98"><sup>98</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R100"><sup>100</sup></xref> it is easy to speculate that these soluble fragments have additional biological functions that need to be investigated.</p><p>Cleavage of transmembrane junctional proteins can directly trigger the activation of pro-proliferative signaling by releasing intracellular scaffolding molecules that often associate with their intracellular domains. For instance, intracellular cleavage of E-cadherin and N-cadherin promotes translocation of &#x003b2;-catenin from the plasmamembrane to nucleus thereby resulting in &#x003b2;-catenin/TCF transactivation and increase in cell proliferation.<xref ref-type="bibr" rid="R43"><sup>43</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R84"><sup>84</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R92"><sup>92</sup></xref> In addition to its role in cell proliferation, &#x003b2;-catenin transactivation can also increase the expression and secretion of metalloproteases.<xref ref-type="bibr" rid="R101"><sup>101</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R102"><sup>102</sup></xref> Thus, it is tempting to speculate that &#x003b2;-catenin redistribution after E-cadherin or N-cadherin cleavage could result in the activation of metalloproteases that in turn enhance shedding of their ectodomains. This process will increase epithelial cell proliferation through stimulating RTK receptors in a paracrine manner.</p></sec><sec><title>Relevance to Pathologic States</title><sec><title>Cancer</title><p>A continuous turnover of intercellular junction proteins in healthy individuals is required for the maintenance of epithelial tissues and therefore, a low level of E-cadherin cleavage product has been observed in the healthy serum.<xref ref-type="bibr" rid="R99"><sup>99</sup></xref> However, in pathological conditions such as inflammation and cancer, proteolytic activity is increased.<xref ref-type="bibr" rid="R103"><sup>103</sup></xref> Since cleavage products have biological activity that influences cell-cell adhesion, migration and proliferation, they contribute to the pathogenesis of disease. As a result, increased soluble junctional proteins such as E-cadherin,<xref ref-type="bibr" rid="R40"><sup>40</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R99"><sup>99</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R104"><sup>104</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R106"><sup>106</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R116"><sup>116</sup></xref> N-cadherin,<xref ref-type="bibr" rid="R105"><sup>105</sup></xref> and nectin<xref ref-type="bibr" rid="R49"><sup>49</sup></xref> can be observed in body fluids (serum, urine and ascites) and cancer tissue of patients. Given the ectodomain stability of cell junction proteins in several body fluids, the detection of cleavage products as biomarkers for disease has been considered. For example, increased sE-cadherin is seen in serum or at other sites (cancer tissue, urine, cyst and ascites) in cancer patients. Such cleavage product has been detected in cancers from many areas that include bladder,<xref ref-type="bibr" rid="R106"><sup>106</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R107"><sup>107</sup></xref> colorectal,<xref ref-type="bibr" rid="R108"><sup>108</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R109"><sup>109</sup></xref> esophageal squamous cell carcinoma,<xref ref-type="bibr" rid="R104"><sup>104</sup></xref> gastric,<xref ref-type="bibr" rid="R99"><sup>99</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R110"><sup>110</sup></xref> liver,<xref ref-type="bibr" rid="R99"><sup>99</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R111"><sup>111</sup></xref> lung,<xref ref-type="bibr" rid="R112"><sup>112</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R113"><sup>113</sup></xref> ovarian,<xref ref-type="bibr" rid="R41"><sup>41</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R114"><sup>114</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R115"><sup>115</sup></xref> prostate,<xref ref-type="bibr" rid="R116"><sup>116</sup></xref> and skin tissue.<xref ref-type="bibr" rid="R117"><sup>117</sup></xref> Given the biological function of intercellular junction protein ectodomains, their upregulation may play a role in the progression of cancer and metastasis. However, some reports have failed to detect increased serum E-cadherin cleaved products in some cancer patients.<xref ref-type="bibr" rid="R118"><sup>118</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R120"><sup>120</sup></xref> Thus, additional studies are needed to verify the role of such cleavage products in cancer pathogenesis and detection. Analogous to E-cadherin, the ectodomains of nectin-4 are increased in the serum of patients with metastatic ductal breast carcinoma compared with healthy subjects.<xref ref-type="bibr" rid="R49"><sup>49</sup></xref> Furthermore, soluble N-cadherin is significantly elevated in serum of prostate cancer patients.<xref ref-type="bibr" rid="R105"><sup>105</sup></xref> These findings indicate the potential use of such products as diagnostic tools.</p></sec><sec><title>Inflammation</title><p>Knowledge of junctional protein cleavage fragments in inflammation is limited compared with cancer reports. Mayerle et al. have shown that leukocyte elastase cleaves extracellular domain of E-cadherin and disrupt cell-cell contacts in the rat pancreas, thereby promoting leukocyte transmigration into epithelial tissues in the initial phase of experimental pancreatitis.<xref ref-type="bibr" rid="R100"><sup>100</sup></xref> Furthermore, extracellular cleavage of Dsg1 by <italic>Staphylococcus aureus</italic> exfoliative toxin A (serine protease) disrupts cell-cell adhesion, which leads to bullous impetigo or Staphylococcal scalded skin syndrome.<xref ref-type="bibr" rid="R50"><sup>50</sup></xref><sup>,</sup><xref ref-type="bibr" rid="R52"><sup>52</sup></xref><sup>-</sup><xref ref-type="bibr" rid="R54"><sup>54</sup></xref> These reports suggest that the extracellular cleavage of intercellular junction proteins disrupts cell-cell adhesion contributing to loss of epithelial barrier function and mucosal inflammation. However, the utility of detecting junctional protein cleavage products as inflammation biomarkers remains incompletely understood. Pittard et al. identified increased concentration of sE-cadherin in patients with systemic inflammatory response syndrome and multi-organ dysfunction.<xref ref-type="bibr" rid="R98"><sup>98</sup></xref> On the contrary, Weiss at al. did not observe significant difference in serum sE-cadherin in healthy control individuals and patients with inflammatory bowel disease.<xref ref-type="bibr" rid="R109"><sup>109</sup></xref> The presence of the ectodomains of other junction proteins such as JAM-A and JAM-C<xref ref-type="bibr" rid="R121"><sup>121</sup></xref> in body fluids suggests a putative role of these fragments as diagnostic tools in such pathologies.</p></sec><sec><title>Others</title><p>Cleavage of transmembrane junction proteins has been observed in several other pathologies. Dry eye disease is a common disease that develops as a result of changes in tear fluid, leading to osmotic stress and perturbed epithelial barrier function. Huet et al. have shown a relationship of MMP9-mediated cleavage of occludin in human corneal epithelial cells and dry eye disease.<xref ref-type="bibr" rid="R28"><sup>28</sup></xref> In HIV infection, abnormal distribution of E-cadherin has been observed in the intestinal epithelium, which leads to increased systemic levels of sE-cadherin. Additionally, sE-cadherin level in plasma correlates with viral load in HIV patients. Interestingly, sE-cadherin can inhibit HIV-1-specific antiviral activity of CD8<sup>+</sup> T-cell function.<xref ref-type="bibr" rid="R122"><sup>122</sup></xref> Thus, cleavage products of intercellular junctional proteins also regulate immune response. Additionally, it has to be noted that some pathological states induced by bacterial pathogens such as diarrhea<xref ref-type="bibr" rid="R45"><sup>45</sup></xref> and skin blister formation<xref ref-type="bibr" rid="R123"><sup>123</sup></xref> are mediated by targeting extracellular domains of cell adhesion molecules by bacterial proteases.</p></sec></sec><sec sec-type="conclusions"><title>Conclusion</title><p>A continuous turnover of transmembrane intercellular junction proteins is observed in healthy individuals and is required for the maintenance of epithelial barriers. Physiologically low levels of cleavage products have been identified in the serum. The cleavage products are generated by a variety of proteases during epithelial cell junction rearrangement. Extracellular proteases such as MMP, ADAM, &#x003b3;-secretase, serine and bacterial proteases can cleave the ectodomain of the proteins. On the other hand, proteases including calpain and caspase cleave intracellular domain of junction transmembrane proteins. Interestingly, the cleavage products generated by these proteases have distinct biological functions. In pathological conditions such as cancer and inflammation, increased junction protein cleavage products are often detected in the tissue and body fluids. These cleavage products influence epithelial behavior that includes proliferation, migration and apoptosis. In addition to exerting biological activity, detection of junction protein cleavage fragment can serve as biomarkers to follow disease progression.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by an American Gastroenterological Association Research Scholar Award (P.N.), a Crohn&#x02019;s and Colitis Foundation of America Career Development Award (P.N.) and a CONACyT grant 175854 (P.N.), the 12th Glaxo-SmithKline International Award from Japan Society of Immunology and Allergology in Otolaryngology (R.K.) and National Institutes of Health grants DK059888 and DK055679 (A.N.).</p></ack><fn-group><fn fn-type="other"><p>Previously published online: <ext-link ext-link-type="uri" xlink:href="http://www.landesbioscience.com/journals/tissuebarriers/article/24783/">www.landesbioscience.com/journals/tissuebarriers/article/24783</ext-link></p></fn></fn-group><glossary><def-list id="DL1"><title>Abbreviations: </title><def-item><term>TJ</term><def><p>tight junction</p></def></def-item><def-item><term>AJ</term><def><p>adherens junction</p></def></def-item><def-item><term>DM</term><def><p>desmosome</p></def></def-item><def-item><term>CTX</term><def><p>cortical thymocyte marker in Xenopus</p></def></def-item><def-item><term>JAM-A</term><def><p>junctional adhesion molecule A</p></def></def-item><def-item><term>CAR</term><def><p>coxsackie adenovirus receptor</p></def></def-item><def-item><term>CLMP</term><def><p>CAR-like membrane protein</p></def></def-item><def-item><term>ZO</term><def><p>zonula occludens</p></def></def-item><def-item><term>MAGI</term><def><p>membrane-associated guanylate kinase with inverted orientation</p></def></def-item><def-item><term>E-cadherin</term><def><p>epithelial-cadherin</p></def></def-item><def-item><term>N-cadherin</term><def><p>neural-cadherin</p></def></def-item><def-item><term>P-cadherin</term><def><p>placental-cadherin</p></def></def-item><def-item><term>AF</term><def><p>afadin</p></def></def-item><def-item><term>Dsg</term><def><p>desmoglein</p></def></def-item><def-item><term>Dsc</term><def><p>desmocollin</p></def></def-item><def-item><term>MMP</term><def><p>matrix metalloprotease</p></def></def-item><def-item><term>ADAM</term><def><p>a disintegrin and metalloprotease</p></def></def-item><def-item><term>EMMPRIN</term><def><p>extracellular matrix metalloprotease inducer</p></def></def-item><def-item><term>IFN-&#x003b3;</term><def><p>interferon<italic>-</italic>gamma</p></def></def-item><def-item><term>sE-cadherin</term><def><p>soluble E-cadherin</p></def></def-item><def-item><term>EGFR</term><def><p>epidermal growth factor receptor</p></def></def-item><def-item><term>HtrA</term><def><p>high temperature requirement protease A</p></def></def-item><def-item><term>SPINK5</term><def><p>serine protease inhibitor of kazal type 5</p></def></def-item><def-item><term>HAV</term><def><p>His-Ala-Val</p></def></def-item><def-item><term>EC</term><def><p>extracellular</p></def></def-item><def-item><term>MT1-MMP</term><def><p>membrane-type matrix metalloprotease</p></def></def-item><def-item><term>HER</term><def><p>human epidermal growth factor receptor</p></def></def-item><def-item><term>PI3K</term><def><p>phosphoinositide-3 kinase</p></def></def-item><def-item><term>mTOR</term><def><p>mammalian target of rapamycin</p></def></def-item><def-item><term>MAPK</term><def><p>mitogen-activated protein kinase</p></def></def-item><def-item><term>ERK</term><def><p>extracellular signal-regulated kinase</p></def></def-item><def-item><term>TLR</term><def><p>toll-like receptor</p></def></def-item><def-item><term>STAT</term><def><p>signal transducer and activator of transcription</p></def></def-item><def-item><term>CTF</term><def><p>C-terminal fragment</p></def></def-item><def-item><term>Tcf</term><def><p>T cell factor</p></def></def-item><def-item><term>EpCAM</term><def><p>epithelial cell adhesion molecule</p></def></def-item><def-item><term>FHL2</term><def><p>four and a half LIM-domain protein</p></def></def-item><def-item><term>Lef</term><def><p>lymphoid enhancer-binding factor</p></def></def-item><def-item><term>RTK</term><def><p>receptor tyrosine kinases</p></def></def-item><def-item><term>HIV</term><def><p>human immunodeficiency virus</p></def></def-item><def-item><term>TACE</term><def><p>tumor necrosis factor-&#x003b1;-converting enzyme</p></def></def-item><def-item><term>TGF&#x003b2;</term><def><p>transforming growth factor-beta</p></def></def-item><def-item><term>IL-1&#x003b2;</term><def><p>interleukin-1 beta</p></def></def-item><def-item><term>LPS</term><def><p>lipopolysaccharide</p></def></def-item><def-item><term>TNF&#x003b1;</term><def><p>tumor necrosis factor-alpha</p></def></def-item><def-item><term>PMA</term><def><p>phorbol-12-myristate-13-acetate</p></def></def-item><def-item><term>PKD1</term><def><p>protein kinase D1</p></def></def-item><def-item><term>HGF/SF</term><def><p>hepatocyte growth factor/scatter factor</p></def></def-item><def-item><term>EGF</term><def><p>epidermal growth factor</p></def></def-item><def-item><term>LPA</term><def><p>lysophosphatidic acid</p></def></def-item><def-item><term>TPA</term><def><p>12-O-tetradecanoylphorbol-13-acetate</p></def></def-item><def-item><term>PMN</term><def><p>polymorphonuclear leukocyte</p></def></def-item><def-item><term>IGF1R</term><def><p>insulin-like growth factor 1 receptor</p></def></def-item><def-item><term>NTF</term><def><p>N-terminal fragment</p></def></def-item><def-item><term>EA</term><def><p>extracellular anchor</p></def></def-item></def-list></glossary><notes><title>Disclosure of Potential Conflicts of Interest</title><p>No potential conflict of interest was disclosed.</p></notes><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farquhar</surname><given-names>MG</given-names></name><name><surname>Palade</surname><given-names>GE</given-names></name></person-group><article-title>Junctional complexes in various epithelia</article-title><source>J Cell Biol</source><year>1963</year><volume>17</volume><fpage>375</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1083/jcb.17.2.375</pub-id><pub-id pub-id-type="pmid">13944428</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukita</surname><given-names>S</given-names></name><name><surname>Furuse</surname><given-names>M</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name></person-group><article-title>Multifunctional strands in tight junctions</article-title><source>Nat Rev Mol Cell Biol</source><year>2001</year><volume>2</volume><fpage>285</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1038/35067088</pub-id><pub-id pub-id-type="pmid">11283726</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawada</surname><given-names>N</given-names></name><name><surname>Murata</surname><given-names>M</given-names></name><name><surname>Kikuchi</surname><given-names>K</given-names></name><name><surname>Osanai</surname><given-names>M</given-names></name><name><surname>Tobioka</surname><given-names>H</given-names></name><name><surname>Kojima</surname><given-names>T</given-names></name><etal/></person-group><article-title>Tight junctions and human diseases</article-title><source>Med Electron Microsc</source><year>2003</year><volume>36</volume><fpage>147</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1007/s00795-003-0219-y</pub-id><pub-id pub-id-type="pmid">14505058</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneeberger</surname><given-names>EE</given-names></name><name><surname>Lynch</surname><given-names>RD</given-names></name></person-group><article-title>The tight junction: a multifunctional complex</article-title><source>Am J Physiol Cell Physiol</source><year>2004</year><volume>286</volume><fpage>C1213</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00558.2003</pub-id><pub-id pub-id-type="pmid">15151915</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikenouchi</surname><given-names>J</given-names></name><name><surname>Furuse</surname><given-names>M</given-names></name><name><surname>Furuse</surname><given-names>K</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Tsukita</surname><given-names>S</given-names></name><name><surname>Tsukita</surname><given-names>S</given-names></name></person-group><article-title>Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells</article-title><source>J Cell Biol</source><year>2005</year><volume>171</volume><fpage>939</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1083/jcb.200510043</pub-id><pub-id pub-id-type="pmid">16365161</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balda</surname><given-names>MS</given-names></name><name><surname>Matter</surname><given-names>K</given-names></name></person-group><article-title>Tight junctions at a glance</article-title><source>J Cell Sci</source><year>2008</year><volume>121</volume><fpage>3677</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1242/jcs.023887</pub-id><pub-id pub-id-type="pmid">18987354</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niessen</surname><given-names>CM</given-names></name></person-group><article-title>Tight junctions/adherens junctions: basic structure and function</article-title><source>J Invest Dermatol</source><year>2007</year><volume>127</volume><fpage>2525</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1038/sj.jid.5700865</pub-id><pub-id pub-id-type="pmid">17934504</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>TJ</given-names></name><name><surname>Tepass</surname><given-names>U</given-names></name></person-group><article-title>Adherens junctions: from molecules to morphogenesis</article-title><source>Nat Rev Mol Cell Biol</source><year>2010</year><volume>11</volume><fpage>502</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/nrm2927</pub-id><pub-id pub-id-type="pmid">20571587</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>WJ</given-names></name><name><surname>Nusse</surname><given-names>R</given-names></name></person-group><article-title>Convergence of Wnt, &#x003b2;-catenin, and cadherin pathways</article-title><source>Science</source><year>2004</year><volume>303</volume><fpage>1483</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1126/science.1094291</pub-id><pub-id pub-id-type="pmid">15001769</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brembeck</surname><given-names>FH</given-names></name><name><surname>Ros&#x000e1;rio</surname><given-names>M</given-names></name><name><surname>Birchmeier</surname><given-names>W</given-names></name></person-group><article-title>Balancing cell adhesion and Wnt signaling, the key role of &#x003b2;-catenin</article-title><source>Curr Opin Genet Dev</source><year>2006</year><volume>16</volume><fpage>51</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.gde.2005.12.007</pub-id><pub-id pub-id-type="pmid">16377174</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dusek</surname><given-names>RL</given-names></name><name><surname>Godsel</surname><given-names>LM</given-names></name><name><surname>Green</surname><given-names>KJ</given-names></name></person-group><article-title>Discriminating roles of desmosomal cadherins: beyond desmosomal adhesion</article-title><source>J Dermatol Sci</source><year>2007</year><volume>45</volume><fpage>7</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2006.10.006</pub-id><pub-id pub-id-type="pmid">17141479</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holth&#x000f6;fer</surname><given-names>B</given-names></name><name><surname>Windoffer</surname><given-names>R</given-names></name><name><surname>Troyanovsky</surname><given-names>S</given-names></name><name><surname>Leube</surname><given-names>RE</given-names></name></person-group><article-title>Structure and function of desmosomes</article-title><source>Int Rev Cytol</source><year>2007</year><volume>264</volume><fpage>65</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1016/S0074-7696(07)64003-0</pub-id><pub-id pub-id-type="pmid">17964922</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>KJ</given-names></name><name><surname>Simpson</surname><given-names>CL</given-names></name></person-group><article-title>Desmosomes: new perspectives on a classic</article-title><source>J Invest Dermatol</source><year>2007</year><volume>127</volume><fpage>2499</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1038/sj.jid.5701015</pub-id><pub-id pub-id-type="pmid">17934502</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nava</surname><given-names>P</given-names></name><name><surname>Laukoetter</surname><given-names>MG</given-names></name><name><surname>Hopkins</surname><given-names>AM</given-names></name><name><surname>Laur</surname><given-names>O</given-names></name><name><surname>Gerner-Smidt</surname><given-names>K</given-names></name><name><surname>Green</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Desmoglein-2: a novel regulator of apoptosis in the intestinal epithelium</article-title><source>Mol Biol Cell</source><year>2007</year><volume>18</volume><fpage>4565</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1091/mbc.E07-05-0426</pub-id><pub-id pub-id-type="pmid">17804817</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamora</surname><given-names>C</given-names></name><name><surname>Fuchs</surname><given-names>E</given-names></name></person-group><article-title>Intercellular adhesion, signalling and the cytoskeleton</article-title><source>Nat Cell Biol</source><year>2002</year><volume>4</volume><fpage>E101</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/ncb0402-e101</pub-id><pub-id pub-id-type="pmid">11944044</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amagai</surname><given-names>M</given-names></name><name><surname>Klaus-Kovtun</surname><given-names>V</given-names></name><name><surname>Stanley</surname><given-names>JR</given-names></name></person-group><article-title>Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion</article-title><source>Cell</source><year>1991</year><volume>67</volume><fpage>869</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(91)90360-B</pub-id><pub-id pub-id-type="pmid">1720352</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>EM</given-names></name><name><surname>Giudice</surname><given-names>GJ</given-names></name><name><surname>Diaz</surname><given-names>LA</given-names></name></person-group><article-title>Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein</article-title><source>J Invest Dermatol</source><year>1993</year><volume>100</volume><fpage>685</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1111/1523-1747.ep12472348</pub-id><pub-id pub-id-type="pmid">8491991</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waschke</surname><given-names>J</given-names></name></person-group><article-title>The desmosome and pemphigus</article-title><source>Histochem Cell Biol</source><year>2008</year><volume>130</volume><fpage>21</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1007/s00418-008-0420-0</pub-id><pub-id pub-id-type="pmid">18386043</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>KM</given-names></name><name><surname>Francis</surname><given-names>SA</given-names></name><name><surname>McCormack</surname><given-names>JM</given-names></name><name><surname>Lai</surname><given-names>J</given-names></name><name><surname>Rogers</surname><given-names>RA</given-names></name><name><surname>Skare</surname><given-names>IB</given-names></name><etal/></person-group><article-title>Inducible expression of claudin-1-myc but not occludin-VSV-G results in aberrant tight junction strand formation in MDCK cells</article-title><source>J Cell Sci</source><year>2000</year><volume>113</volume><fpage>3387</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">10984430</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanov</surname><given-names>AI</given-names></name><name><surname>Nusrat</surname><given-names>A</given-names></name><name><surname>Parkos</surname><given-names>CA</given-names></name></person-group><article-title>Endocytosis of the apical junctional complex: mechanisms and possible roles in regulation of epithelial barriers</article-title><source>Bioessays</source><year>2005</year><volume>27</volume><fpage>356</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1002/bies.20203</pub-id><pub-id pub-id-type="pmid">15770686</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utech</surname><given-names>M</given-names></name><name><surname>Ivanov</surname><given-names>AI</given-names></name><name><surname>Samarin</surname><given-names>SN</given-names></name><name><surname>Bruewer</surname><given-names>M</given-names></name><name><surname>Turner</surname><given-names>JR</given-names></name><name><surname>Mrsny</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Mechanism of IFN-&#x003b3;-induced endocytosis of tight junction proteins: myosin II-dependent vacuolarization of the apical plasma membrane</article-title><source>Mol Biol Cell</source><year>2005</year><volume>16</volume><fpage>5040</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1091/mbc.E05-03-0193</pub-id><pub-id pub-id-type="pmid">16055505</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>NJ</given-names></name><name><surname>Yeaman</surname><given-names>C</given-names></name></person-group><article-title>Sec3-containing exocyst complex is required for desmosome assembly in mammalian epithelial cells</article-title><source>Mol Biol Cell</source><year>2010</year><volume>21</volume><fpage>152</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1091/mbc.E09-06-0459</pub-id><pub-id pub-id-type="pmid">19889837</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rios-Doria</surname><given-names>J</given-names></name><name><surname>Day</surname><given-names>KC</given-names></name><name><surname>Kuefer</surname><given-names>R</given-names></name><name><surname>Rashid</surname><given-names>MG</given-names></name><name><surname>Chinnaiyan</surname><given-names>AM</given-names></name><name><surname>Rubin</surname><given-names>MA</given-names></name><etal/></person-group><article-title>The role of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>1372</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1074/jbc.M208772200</pub-id><pub-id pub-id-type="pmid">12393869</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowalczyk</surname><given-names>AP</given-names></name><name><surname>Nanes</surname><given-names>BA</given-names></name></person-group><article-title>Adherens junction turnover: regulating adhesion through cadherin endocytosis, degradation, and recycling</article-title><source>Subcell Biochem</source><year>2012</year><volume>60</volume><fpage>197</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1007/978-94-007-4186-7_9</pub-id><pub-id pub-id-type="pmid">22674073</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCawley</surname><given-names>LJ</given-names></name><name><surname>Matrisian</surname><given-names>LM</given-names></name></person-group><article-title>Matrix metalloproteinases: they&#x02019;re not just for matrix anymore!</article-title><source>Curr Opin Cell Biol</source><year>2001</year><volume>13</volume><fpage>534</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1016/S0955-0674(00)00248-9</pub-id><pub-id pub-id-type="pmid">11544020</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabowska</surname><given-names>MM</given-names></name><name><surname>Day</surname><given-names>ML</given-names></name></person-group><article-title>Soluble E-cadherin: more than a symptom of disease</article-title><source>Front Biosci</source><year>2012</year><volume>17</volume><fpage>1948</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.2741/4031</pub-id><pub-id pub-id-type="pmid">22201848</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marambaud</surname><given-names>P</given-names></name><name><surname>Shioi</surname><given-names>J</given-names></name><name><surname>Serban</surname><given-names>G</given-names></name><name><surname>Georgakopoulos</surname><given-names>A</given-names></name><name><surname>Sarner</surname><given-names>S</given-names></name><name><surname>Nagy</surname><given-names>V</given-names></name><etal/></person-group><article-title>A presenilin-1/&#x003b3;-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions</article-title><source>EMBO J</source><year>2002</year><volume>21</volume><fpage>1948</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1093/emboj/21.8.1948</pub-id><pub-id pub-id-type="pmid">11953314</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huet</surname><given-names>E</given-names></name><name><surname>Vall&#x000e9;e</surname><given-names>B</given-names></name><name><surname>Delb&#x000e9;</surname><given-names>J</given-names></name><name><surname>Mourah</surname><given-names>S</given-names></name><name><surname>Pruli&#x000e8;re-Escabasse</surname><given-names>V</given-names></name><name><surname>Tremouilleres</surname><given-names>M</given-names></name><etal/></person-group><article-title>EMMPRIN modulates epithelial barrier function through a MMP-mediated occludin cleavage: implications in dry eye disease</article-title><source>Am J Pathol</source><year>2011</year><volume>179</volume><fpage>1278</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2011.05.036</pub-id><pub-id pub-id-type="pmid">21777561</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willemsen</surname><given-names>LE</given-names></name><name><surname>Hoetjes</surname><given-names>JP</given-names></name><name><surname>van Deventer</surname><given-names>SJ</given-names></name><name><surname>van Tol</surname><given-names>EA</given-names></name></person-group><article-title>Abrogation of IFN-&#x003b3; mediated epithelial barrier disruption by serine protease inhibition</article-title><source>Clin Exp Immunol</source><year>2005</year><volume>142</volume><fpage>275</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2249.2005.02906.x</pub-id><pub-id pub-id-type="pmid">16232214</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wan</surname><given-names>H</given-names></name><name><surname>Winton</surname><given-names>HL</given-names></name><name><surname>Soeller</surname><given-names>C</given-names></name><name><surname>Gruenert</surname><given-names>DC</given-names></name><name><surname>Thompson</surname><given-names>PJ</given-names></name><name><surname>Cannell</surname><given-names>MB</given-names></name><etal/></person-group><article-title>Quantitative structural and biochemical analyses of tight junction dynamics following exposure of epithelial cells to house dust mite allergen Der p 1</article-title><source>Clin Exp Allergy</source><year>2000</year><volume>30</volume><fpage>685</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1046/j.1365-2222.2000.00820.x</pub-id><pub-id pub-id-type="pmid">10792361</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Nybom</surname><given-names>P</given-names></name><name><surname>Magnusson</surname><given-names>KE</given-names></name></person-group><article-title>Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1</article-title><source>Cell Microbiol</source><year>2000</year><volume>2</volume><fpage>11</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1046/j.1462-5822.2000.00025.x</pub-id><pub-id pub-id-type="pmid">11207559</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000fc;cker</surname><given-names>R</given-names></name><name><surname>Krug</surname><given-names>SM</given-names></name><name><surname>Rosenthal</surname><given-names>R</given-names></name><name><surname>G&#x000fc;nzel</surname><given-names>D</given-names></name><name><surname>Fromm</surname><given-names>A</given-names></name><name><surname>Zeitz</surname><given-names>M</given-names></name><etal/></person-group><article-title>Aerolysin from Aeromonas hydrophila perturbs tight junction integrity and cell lesion repair in intestinal epithelial HT-29/B6 cells</article-title><source>J Infect Dis</source><year>2011</year><volume>204</volume><fpage>1283</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1093/infdis/jir504</pub-id><pub-id pub-id-type="pmid">21917902</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Runswick</surname><given-names>S</given-names></name><name><surname>Mitchell</surname><given-names>T</given-names></name><name><surname>Davies</surname><given-names>P</given-names></name><name><surname>Robinson</surname><given-names>C</given-names></name><name><surname>Garrod</surname><given-names>DR</given-names></name></person-group><article-title>Pollen proteolytic enzymes degrade tight junctions</article-title><source>Respirology</source><year>2007</year><volume>12</volume><fpage>834</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1843.2007.01175.x</pub-id><pub-id pub-id-type="pmid">17986111</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heijink</surname><given-names>IH</given-names></name><name><surname>van Oosterhout</surname><given-names>A</given-names></name><name><surname>Kapus</surname><given-names>A</given-names></name></person-group><article-title>Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction</article-title><source>Eur Respir J</source><year>2010</year><volume>36</volume><fpage>1016</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1183/09031936.00125809</pub-id><pub-id pub-id-type="pmid">20351035</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenen</surname><given-names>RR</given-names></name><name><surname>Pruessmeyer</surname><given-names>J</given-names></name><name><surname>Soehnlein</surname><given-names>O</given-names></name><name><surname>Fraemohs</surname><given-names>L</given-names></name><name><surname>Zernecke</surname><given-names>A</given-names></name><name><surname>Schwarz</surname><given-names>N</given-names></name><etal/></person-group><article-title>Regulated release and functional modulation of junctional adhesion molecule A by disintegrin metalloproteinases</article-title><source>Blood</source><year>2009</year><volume>113</volume><fpage>4799</fpage><lpage>809</lpage><pub-id pub-id-type="doi">10.1182/blood-2008-04-152330</pub-id><pub-id pub-id-type="pmid">19258599</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Irie</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>K</given-names></name><name><surname>Sakisaka</surname><given-names>T</given-names></name><name><surname>Ikeda</surname><given-names>W</given-names></name></person-group><article-title>Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization</article-title><source>Cancer Sci</source><year>2003</year><volume>94</volume><fpage>655</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1111/j.1349-7006.2003.tb01499.x</pub-id><pub-id pub-id-type="pmid">12901789</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>M</given-names></name><name><surname>Tucker</surname><given-names>DK</given-names></name><name><surname>Kohlhorst</surname><given-names>D</given-names></name><name><surname>Niessen</surname><given-names>CM</given-names></name><name><surname>Kowalczyk</surname><given-names>AP</given-names></name></person-group><article-title>Classical and desmosomal cadherins at a glance</article-title><source>J Cell Sci</source><year>2012</year><volume>125</volume><fpage>2547</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1242/jcs.066654</pub-id><pub-id pub-id-type="pmid">22833291</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Bras</surname><given-names>GF</given-names></name><name><surname>Taubenslag</surname><given-names>KJ</given-names></name><name><surname>Andl</surname><given-names>CD</given-names></name></person-group><article-title>The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression</article-title><source>Cell Adh Migr</source><year>2012</year><volume>6</volume><fpage>365</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.4161/cam.21326</pub-id><pub-id pub-id-type="pmid">22796940</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>G</given-names></name><name><surname>Jiang</surname><given-names>WG</given-names></name><name><surname>Mason</surname><given-names>MD</given-names></name></person-group><article-title>Matrilysin mediates extracellular cleavage of E-cadherin from prostate cancer cells: a key mechanism in hepatocyte growth factor/scatter factor-induced cell-cell dissociation and in vitro invasion</article-title><source>Clin Cancer Res</source><year>2001</year><volume>7</volume><fpage>3289</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">11595727</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>No&#x000eb;</surname><given-names>V</given-names></name><name><surname>Fingleton</surname><given-names>B</given-names></name><name><surname>Jacobs</surname><given-names>K</given-names></name><name><surname>Crawford</surname><given-names>HC</given-names></name><name><surname>Vermeulen</surname><given-names>S</given-names></name><name><surname>Steelant</surname><given-names>W</given-names></name><etal/></person-group><article-title>Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1</article-title><source>J Cell Sci</source><year>2001</year><volume>114</volume><fpage>111</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11112695</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Symowicz</surname><given-names>J</given-names></name><name><surname>Adley</surname><given-names>BP</given-names></name><name><surname>Gleason</surname><given-names>KJ</given-names></name><name><surname>Johnson</surname><given-names>JJ</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Fishman</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells</article-title><source>Cancer Res</source><year>2007</year><volume>67</volume><fpage>2030</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-2808</pub-id><pub-id pub-id-type="pmid">17332331</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inge</surname><given-names>LJ</given-names></name><name><surname>Barwe</surname><given-names>SP</given-names></name><name><surname>D&#x02019;Ambrosio</surname><given-names>J</given-names></name><name><surname>Gopal</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>K</given-names></name><name><surname>Ryazantsev</surname><given-names>S</given-names></name><etal/></person-group><article-title>Soluble E-cadherin promotes cell survival by activating epidermal growth factor receptor</article-title><source>Exp Cell Res</source><year>2011</year><volume>317</volume><fpage>838</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2010.12.025</pub-id><pub-id pub-id-type="pmid">21211535</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maretzky</surname><given-names>T</given-names></name><name><surname>Reiss</surname><given-names>K</given-names></name><name><surname>Ludwig</surname><given-names>A</given-names></name><name><surname>Buchholz</surname><given-names>J</given-names></name><name><surname>Scholz</surname><given-names>F</given-names></name><name><surname>Proksch</surname><given-names>E</given-names></name><etal/></person-group><article-title>ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and &#x003b2;-catenin translocation</article-title><source>Proc Natl Acad Sci U S A</source><year>2005</year><volume>102</volume><fpage>9182</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1073/pnas.0500918102</pub-id><pub-id pub-id-type="pmid">15958533</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoy</surname><given-names>B</given-names></name><name><surname>Geppert</surname><given-names>T</given-names></name><name><surname>Boehm</surname><given-names>M</given-names></name><name><surname>Reisen</surname><given-names>F</given-names></name><name><surname>Plattner</surname><given-names>P</given-names></name><name><surname>Gadermaier</surname><given-names>G</given-names></name><etal/></person-group><article-title>Distinct roles of secreted HtrA proteases from gram-negative pathogens in cleaving the junctional protein and tumor suppressor E-cadherin</article-title><source>J Biol Chem</source><year>2012</year><volume>287</volume><fpage>10115</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1074/jbc.C111.333419</pub-id><pub-id pub-id-type="pmid">22337879</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Lim</surname><given-names>KC</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Saidi</surname><given-names>RF</given-names></name><name><surname>Sears</surname><given-names>CL</given-names></name></person-group><article-title>Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin</article-title><source>Proc Natl Acad Sci U S A</source><year>1998</year><volume>95</volume><fpage>14979</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.25.14979</pub-id><pub-id pub-id-type="pmid">9844001</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>QB</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Potempa</surname><given-names>J</given-names></name><name><surname>Travis</surname><given-names>J</given-names></name><name><surname>Michalek</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Hydrolysis of epithelial junctional proteins by Porphyromonas gingivalis gingipains</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><fpage>2512</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1128/IAI.70.5.2512-2518.2002</pub-id><pub-id pub-id-type="pmid">11953390</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>ST</given-names></name><name><surname>Chang</surname><given-names>A</given-names></name><name><surname>Giuliano</surname><given-names>RE</given-names></name><name><surname>Federoff</surname><given-names>HJ</given-names></name></person-group><article-title>Ectodomain shedding of nectin-1 regulates the maintenance of dendritic spine density</article-title><source>J Neurochem</source><year>2012</year><volume>120</volume><fpage>741</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07592.x</pub-id><pub-id pub-id-type="pmid">22118475</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Irie</surname><given-names>K</given-names></name><name><surname>Hirota</surname><given-names>T</given-names></name><name><surname>Sakisaka</surname><given-names>T</given-names></name><name><surname>Nakanishi</surname><given-names>H</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name></person-group><article-title>Ectodomain shedding of nectin-1&#x003b1; by SF/HGF and TPA in MDCK cells</article-title><source>Biochem Biophys Res Commun</source><year>2002</year><volume>299</volume><fpage>472</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/S0006-291X(02)02681-5</pub-id><pub-id pub-id-type="pmid">12445825</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabre-Lafay</surname><given-names>S</given-names></name><name><surname>Garrido-Urbani</surname><given-names>S</given-names></name><name><surname>Reymond</surname><given-names>N</given-names></name><name><surname>Gon&#x000e7;alves</surname><given-names>A</given-names></name><name><surname>Dubreuil</surname><given-names>P</given-names></name><name><surname>Lopez</surname><given-names>M</given-names></name></person-group><article-title>Nectin-4, a new serological breast cancer marker, is a substrate for tumor necrosis factor-&#x003b1;-converting enzyme (TACE)/ADAM-17</article-title><source>J Biol Chem</source><year>2005</year><volume>280</volume><fpage>19543</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1074/jbc.M410943200</pub-id><pub-id pub-id-type="pmid">15784625</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>CL</given-names></name><name><surname>Kojima</surname><given-names>S</given-names></name><name><surname>Cooper-Whitehair</surname><given-names>V</given-names></name><name><surname>Getsios</surname><given-names>S</given-names></name><name><surname>Green</surname><given-names>KJ</given-names></name></person-group><article-title>Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein 1: implications for exfoliative toxin-mediated skin blistering</article-title><source>Am J Pathol</source><year>2010</year><volume>177</volume><fpage>2921</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2010.100397</pub-id><pub-id pub-id-type="pmid">21075858</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Shi</surname><given-names>Z</given-names></name><name><surname>Johnson</surname><given-names>JJ</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Stack</surname><given-names>MS</given-names></name></person-group><article-title>Kallikrein-5 promotes cleavage of desmoglein-1 and loss of cell-cell cohesion in oral squamous cell carcinoma</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>9127</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.191361</pub-id><pub-id pub-id-type="pmid">21163944</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Getsios</surname><given-names>S</given-names></name><name><surname>Simpson</surname><given-names>CL</given-names></name><name><surname>Kojima</surname><given-names>S</given-names></name><name><surname>Harmon</surname><given-names>R</given-names></name><name><surname>Sheu</surname><given-names>LJ</given-names></name><name><surname>Dusek</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Desmoglein 1-dependent suppression of EGFR signaling promotes epidermal differentiation and morphogenesis</article-title><source>J Cell Biol</source><year>2009</year><volume>185</volume><fpage>1243</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1083/jcb.200809044</pub-id><pub-id pub-id-type="pmid">19546243</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amagai</surname><given-names>M</given-names></name><name><surname>Matsuyoshi</surname><given-names>N</given-names></name><name><surname>Wang</surname><given-names>ZH</given-names></name><name><surname>Andl</surname><given-names>C</given-names></name><name><surname>Stanley</surname><given-names>JR</given-names></name></person-group><article-title>Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1</article-title><source>Nat Med</source><year>2000</year><volume>6</volume><fpage>1275</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/81385</pub-id><pub-id pub-id-type="pmid">11062541</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanakawa</surname><given-names>Y</given-names></name><name><surname>Schechter</surname><given-names>NM</given-names></name><name><surname>Lin</surname><given-names>C</given-names></name><name><surname>Garza</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><etal/></person-group><article-title>Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome</article-title><source>J Clin Invest</source><year>2002</year><volume>110</volume><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">12093888</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>T</given-names></name><name><surname>Liang</surname><given-names>D</given-names></name><name><surname>Koch</surname><given-names>PJ</given-names></name><name><surname>Hohl</surname><given-names>D</given-names></name><name><surname>Kheradmand</surname><given-names>F</given-names></name><name><surname>Overbeek</surname><given-names>PA</given-names></name></person-group><article-title>Epidermal detachment, desmosomal dissociation, and destabilization of corneodesmosin in Spink5-/- mice</article-title><source>Genes Dev</source><year>2004</year><volume>18</volume><fpage>2354</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1101/gad.1232104</pub-id><pub-id pub-id-type="pmid">15466487</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Descargues</surname><given-names>P</given-names></name><name><surname>Deraison</surname><given-names>C</given-names></name><name><surname>Bonnart</surname><given-names>C</given-names></name><name><surname>Kreft</surname><given-names>M</given-names></name><name><surname>Kishibe</surname><given-names>M</given-names></name><name><surname>Ishida-Yamamoto</surname><given-names>A</given-names></name><etal/></person-group><article-title>Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity</article-title><source>Nat Genet</source><year>2005</year><volume>37</volume><fpage>56</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">15619623</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wadhawan</surname><given-names>V</given-names></name><name><surname>Kolhe</surname><given-names>YA</given-names></name><name><surname>Sangith</surname><given-names>N</given-names></name><name><surname>Gautam</surname><given-names>AK</given-names></name><name><surname>Venkatraman</surname><given-names>P</given-names></name></person-group><article-title>From prediction to experimental validation: desmoglein 2 is a functionally relevant substrate of matriptase in epithelial cells and their reciprocal relationship is important for cell adhesion</article-title><source>Biochem J</source><year>2012</year><volume>447</volume><fpage>61</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1042/BJ20111432</pub-id><pub-id pub-id-type="pmid">22783993</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bech-Serra</surname><given-names>JJ</given-names></name><name><surname>Santiago-Josefat</surname><given-names>B</given-names></name><name><surname>Esselens</surname><given-names>C</given-names></name><name><surname>Saftig</surname><given-names>P</given-names></name><name><surname>Baselga</surname><given-names>J</given-names></name><name><surname>Arribas</surname><given-names>J</given-names></name><etal/></person-group><article-title>Proteomic identification of desmoglein 2 and activated leukocyte cell adhesion molecule as substrates of ADAM17 and ADAM10 by difference gel electrophoresis</article-title><source>Mol Cell Biol</source><year>2006</year><volume>26</volume><fpage>5086</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1128/MCB.02380-05</pub-id><pub-id pub-id-type="pmid">16782893</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sternlicht</surname><given-names>MD</given-names></name><name><surname>Werb</surname><given-names>Z</given-names></name></person-group><article-title>How matrix metalloproteinases regulate cell behavior</article-title><source>Annu Rev Cell Dev Biol</source><year>2001</year><volume>17</volume><fpage>463</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1146/annurev.cellbio.17.1.463</pub-id><pub-id pub-id-type="pmid">11687497</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourboulia</surname><given-names>D</given-names></name><name><surname>Stetler-Stevenson</surname><given-names>WG</given-names></name></person-group><article-title>Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion</article-title><source>Semin Cancer Biol</source><year>2010</year><volume>20</volume><fpage>161</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2010.05.002</pub-id><pub-id pub-id-type="pmid">20470890</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheelock</surname><given-names>MJ</given-names></name><name><surname>Buck</surname><given-names>CA</given-names></name><name><surname>Bechtol</surname><given-names>KB</given-names></name><name><surname>Damsky</surname><given-names>CH</given-names></name></person-group><article-title>Soluble 80-kd fragment of cell-CAM 120/80 disrupts cell-cell adhesion</article-title><source>J Cell Biochem</source><year>1987</year><volume>34</volume><fpage>187</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1002/jcb.240340305</pub-id><pub-id pub-id-type="pmid">3611200</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryniers</surname><given-names>F</given-names></name><name><surname>Stove</surname><given-names>C</given-names></name><name><surname>Goethals</surname><given-names>M</given-names></name><name><surname>Brackenier</surname><given-names>L</given-names></name><name><surname>No&#x000eb;</surname><given-names>V</given-names></name><name><surname>Bracke</surname><given-names>M</given-names></name><etal/></person-group><article-title>Plasmin produces an E-cadherin fragment that stimulates cancer cell invasion</article-title><source>Biol Chem</source><year>2002</year><volume>383</volume><fpage>159</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1515/BC.2002.016</pub-id><pub-id pub-id-type="pmid">11928810</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>SK</given-names></name><name><surname>Ramani</surname><given-names>VC</given-names></name><name><surname>Hennings</surname><given-names>L</given-names></name><name><surname>Haun</surname><given-names>RS</given-names></name></person-group><article-title>Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin</article-title><source>Cancer</source><year>2007</year><volume>109</volume><fpage>1811</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1002/cncr.22606</pub-id><pub-id pub-id-type="pmid">17354228</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afonso</surname><given-names>AA</given-names></name><name><surname>Sobrin</surname><given-names>L</given-names></name><name><surname>Monroy</surname><given-names>DC</given-names></name><name><surname>Selzer</surname><given-names>M</given-names></name><name><surname>Lokeshwar</surname><given-names>B</given-names></name><name><surname>Pflugfelder</surname><given-names>SC</given-names></name></person-group><article-title>Tear fluid gelatinase B activity correlates with IL-1&#x003b1; concentration and fluorescein clearance in ocular rosacea</article-title><source>Invest Ophthalmol Vis Sci</source><year>1999</year><volume>40</volume><fpage>2506</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">10509643</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>VA</given-names></name><name><surname>Rishmawi</surname><given-names>H</given-names></name><name><surname>Hussein</surname><given-names>H</given-names></name><name><surname>Easty</surname><given-names>DL</given-names></name></person-group><article-title>Tear film MMP accumulation and corneal disease</article-title><source>Br J Ophthalmol</source><year>2001</year><volume>85</volume><fpage>147</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1136/bjo.85.2.147</pub-id><pub-id pub-id-type="pmid">11159476</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pflugfelder</surname><given-names>SC</given-names></name><name><surname>Farley</surname><given-names>W</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>LZ</given-names></name><name><surname>de Paiva</surname><given-names>CS</given-names></name><name><surname>Olmos</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Matrix metalloproteinase-9 knockout confers resistance to corneal epithelial barrier disruption in experimental dry eye</article-title><source>Am J Pathol</source><year>2005</year><volume>166</volume><fpage>61</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)62232-8</pub-id><pub-id pub-id-type="pmid">15632000</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>V</given-names></name><name><surname>Gumbiner</surname><given-names>BM</given-names></name></person-group><article-title>A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier</article-title><source>J Cell Biol</source><year>1997</year><volume>136</volume><fpage>399</fpage><lpage>409</lpage><pub-id pub-id-type="doi">10.1083/jcb.136.2.399</pub-id><pub-id pub-id-type="pmid">9015310</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Makagiansar</surname><given-names>IT</given-names></name><name><surname>Avery</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Audus</surname><given-names>KL</given-names></name><name><surname>Siahaan</surname><given-names>TJ</given-names></name></person-group><article-title>Improving the selectivity of HAV-peptides in modulating E-cadherin-E-cadherin interactions in the intercellular junction of MDCK cell monolayers</article-title><source>Pharm Res</source><year>2001</year><volume>18</volume><fpage>446</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1023/A:1011094025008</pub-id><pub-id pub-id-type="pmid">11451030</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nava</surname><given-names>P</given-names></name><name><surname>L&#x000f3;pez</surname><given-names>S</given-names></name><name><surname>Arias</surname><given-names>CF</given-names></name><name><surname>Islas</surname><given-names>S</given-names></name><name><surname>Gonz&#x000e1;lez-Mariscal</surname><given-names>L</given-names></name></person-group><article-title>The rotavirus surface protein VP8 modulates the gate and fence function of tight junctions in epithelial cells</article-title><source>J Cell Sci</source><year>2004</year><volume>117</volume><fpage>5509</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1242/jcs.01425</pub-id><pub-id pub-id-type="pmid">15494377</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mrsny</surname><given-names>RJ</given-names></name><name><surname>Brown</surname><given-names>GT</given-names></name><name><surname>Gerner-Smidt</surname><given-names>K</given-names></name><name><surname>Buret</surname><given-names>AG</given-names></name><name><surname>Meddings</surname><given-names>JB</given-names></name><name><surname>Quan</surname><given-names>C</given-names></name><etal/></person-group><article-title>A key claudin extracellular loop domain is critical for epithelial barrier integrity</article-title><source>Am J Pathol</source><year>2008</year><volume>172</volume><fpage>905</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2008.070698</pub-id><pub-id pub-id-type="pmid">18349130</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyer</surname><given-names>I</given-names></name><name><surname>van Rensburg</surname><given-names>R</given-names></name><name><surname>Strauss</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Persson</surname><given-names>J</given-names></name><etal/></person-group><article-title>Epithelial junction opener JO-1 improves monoclonal antibody therapy of cancer</article-title><source>Cancer Res</source><year>2011</year><volume>71</volume><fpage>7080</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-11-2009</pub-id><pub-id pub-id-type="pmid">21990319</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bendas</surname><given-names>G</given-names></name><name><surname>Borsig</surname><given-names>L</given-names></name></person-group><article-title>Cancer cell adhesion and metastasis: selectins, integrins, and the inhibitory potential of heparins</article-title><source>Int J Cell Biol</source><year>2012</year><volume>2012</volume><fpage>676731</fpage><pub-id pub-id-type="doi">10.1155/2012/676731</pub-id><pub-id pub-id-type="pmid">22505933</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lochter</surname><given-names>A</given-names></name><name><surname>Galosy</surname><given-names>S</given-names></name><name><surname>Muschler</surname><given-names>J</given-names></name><name><surname>Freedman</surname><given-names>N</given-names></name><name><surname>Werb</surname><given-names>Z</given-names></name><name><surname>Bissell</surname><given-names>MJ</given-names></name></person-group><article-title>Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells</article-title><source>J Cell Biol</source><year>1997</year><volume>139</volume><fpage>1861</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1083/jcb.139.7.1861</pub-id><pub-id pub-id-type="pmid">9412478</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xian</surname><given-names>W</given-names></name><name><surname>Schwertfeger</surname><given-names>KL</given-names></name><name><surname>Vargo-Gogola</surname><given-names>T</given-names></name><name><surname>Rosen</surname><given-names>JM</given-names></name></person-group><article-title>Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model</article-title><source>J Cell Biol</source><year>2005</year><volume>171</volume><fpage>663</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1083/jcb.200505098</pub-id><pub-id pub-id-type="pmid">16301332</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brouxhon</surname><given-names>SM</given-names></name><name><surname>Kyrkanides</surname><given-names>S</given-names></name><name><surname>Teng</surname><given-names>X</given-names></name><name><surname>Athar</surname><given-names>M</given-names></name><name><surname>Ghazizadeh</surname><given-names>S</given-names></name><name><surname>Simon</surname><given-names>M</given-names></name><etal/></person-group><article-title>Soluble E-cadherin: a critical oncogene modulating receptor tyrosine kinases, MAPK and PI3K/Akt/mTOR signaling</article-title><source>Oncogene</source><year>2013</year><pub-id pub-id-type="doi">10.1038/onc.2012.563</pub-id><pub-id pub-id-type="pmid">23318419</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nawrocki-Raby</surname><given-names>B</given-names></name><name><surname>Gilles</surname><given-names>C</given-names></name><name><surname>Polette</surname><given-names>M</given-names></name><name><surname>Bruyneel</surname><given-names>E</given-names></name><name><surname>Laronze</surname><given-names>JY</given-names></name><name><surname>Bonnet</surname><given-names>N</given-names></name><etal/></person-group><article-title>Upregulation of MMPs by soluble E-cadherin in human lung tumor cells</article-title><source>Int J Cancer</source><year>2003</year><volume>105</volume><fpage>790</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1002/ijc.11168</pub-id><pub-id pub-id-type="pmid">12767064</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najy</surname><given-names>AJ</given-names></name><name><surname>Day</surname><given-names>KC</given-names></name><name><surname>Day</surname><given-names>ML</given-names></name></person-group><article-title>The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>18393</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1074/jbc.M801329200</pub-id><pub-id pub-id-type="pmid">18434311</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fouquet</surname><given-names>S</given-names></name><name><surname>Lugo-Mart&#x000ed;nez</surname><given-names>VH</given-names></name><name><surname>Faussat</surname><given-names>AM</given-names></name><name><surname>Renaud</surname><given-names>F</given-names></name><name><surname>Cardot</surname><given-names>P</given-names></name><name><surname>Chambaz</surname><given-names>J</given-names></name><etal/></person-group><article-title>Early loss of E-cadherin from cell-cell contacts is involved in the onset of Anoikis in enterocytes</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>43061</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1074/jbc.M405095200</pub-id><pub-id pub-id-type="pmid">15292248</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanza</surname><given-names>A</given-names></name><name><surname>Cirillo</surname><given-names>N</given-names></name></person-group><article-title>Caspase-dependent cleavage of desmoglein 1 depends on the apoptotic stimulus</article-title><source>Br J Dermatol</source><year>2007</year><volume>156</volume><fpage>400</fpage><lpage>2</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2133.2006.07654.x</pub-id><pub-id pub-id-type="pmid">17223900</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinhusen</surname><given-names>U</given-names></name><name><surname>Weiske</surname><given-names>J</given-names></name><name><surname>Badock</surname><given-names>V</given-names></name><name><surname>Tauber</surname><given-names>R</given-names></name><name><surname>Bommert</surname><given-names>K</given-names></name><name><surname>Huber</surname><given-names>O</given-names></name></person-group><article-title>Cleavage and shedding of E-cadherin after induction of apoptosis</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>4972</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1074/jbc.M006102200</pub-id><pub-id pub-id-type="pmid">11076937</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rios-Doria</surname><given-names>J</given-names></name><name><surname>Day</surname><given-names>ML</given-names></name></person-group><article-title>Truncated E-cadherin potentiates cell death in prostate epithelial cells</article-title><source>Prostate</source><year>2005</year><volume>63</volume><fpage>259</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1002/pros.20179</pub-id><pub-id pub-id-type="pmid">15538719</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sumitomo</surname><given-names>T</given-names></name><name><surname>Nakata</surname><given-names>M</given-names></name><name><surname>Higashino</surname><given-names>M</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Terao</surname><given-names>Y</given-names></name><name><surname>Fujinaga</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Streptolysin S contributes to group A streptococcal translocation across an epithelial barrier</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>2750</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.171504</pub-id><pub-id pub-id-type="pmid">21084306</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chun</surname><given-names>J</given-names></name><name><surname>Prince</surname><given-names>A</given-names></name></person-group><article-title>TLR2-induced calpain cleavage of epithelial junctional proteins facilitates leukocyte transmigration</article-title><source>Cell Host Microbe</source><year>2009</year><volume>5</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2008.11.009</pub-id><pub-id pub-id-type="pmid">19154987</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Okamoto</surname><given-names>I</given-names></name><name><surname>Araki</surname><given-names>N</given-names></name><name><surname>Kawano</surname><given-names>Y</given-names></name><name><surname>Nakao</surname><given-names>M</given-names></name><name><surname>Fujiyama</surname><given-names>S</given-names></name><etal/></person-group><article-title>Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of &#x003b2;-catenin from cell-cell contacts</article-title><source>Oncogene</source><year>1999</year><volume>18</volume><fpage>7080</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1203191</pub-id><pub-id pub-id-type="pmid">10597309</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cirillo</surname><given-names>N</given-names></name><name><surname>Lanza</surname><given-names>M</given-names></name><name><surname>De Rosa</surname><given-names>A</given-names></name><name><surname>Cammarota</surname><given-names>M</given-names></name><name><surname>La Gatta</surname><given-names>A</given-names></name><name><surname>Gombos</surname><given-names>F</given-names></name><etal/></person-group><article-title>The most widespread desmosomal cadherin, desmoglein 2, is a novel target of caspase 3-mediated apoptotic machinery</article-title><source>J Cell Biochem</source><year>2008</year><volume>103</volume><fpage>598</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1002/jcb.21431</pub-id><pub-id pub-id-type="pmid">17559062</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolegraff</surname><given-names>K</given-names></name><name><surname>Nava</surname><given-names>P</given-names></name><name><surname>Laur</surname><given-names>O</given-names></name><name><surname>Parkos</surname><given-names>CA</given-names></name><name><surname>Nusrat</surname><given-names>A</given-names></name></person-group><article-title>Characterization of full-length and proteolytic cleavage fragments of desmoglein-2 in native human colon and colonic epithelial cell lines</article-title><source>Cell Adh Migr</source><year>2011</year><volume>5</volume><fpage>306</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.4161/cam.5.4.16911</pub-id><pub-id pub-id-type="pmid">21715983</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuckerman</surname><given-names>JD</given-names></name><name><surname>Lee</surname><given-names>WY</given-names></name><name><surname>DelGaudio</surname><given-names>JM</given-names></name><name><surname>Moore</surname><given-names>CE</given-names></name><name><surname>Nava</surname><given-names>P</given-names></name><name><surname>Nusrat</surname><given-names>A</given-names></name><etal/></person-group><article-title>Pathophysiology of nasal polyposis: the role of desmosomal junctions</article-title><source>Am J Rhinol</source><year>2008</year><volume>22</volume><fpage>589</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.2500/ajr.2008.22.3235</pub-id><pub-id pub-id-type="pmid">19178795</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>D</given-names></name><name><surname>Peltonen</surname><given-names>S</given-names></name><name><surname>Dowling</surname><given-names>A</given-names></name><name><surname>Medhat</surname><given-names>W</given-names></name><name><surname>Green</surname><given-names>KJ</given-names></name><name><surname>Wahl</surname><given-names>JK</given-names><suffix>3rd</suffix></name><etal/></person-group><article-title>A role for caveolin-1 in desmoglein binding and desmosome dynamics</article-title><source>Oncogene</source><year>2012</year><volume>31</volume><fpage>1636</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1038/onc.2011.346</pub-id><pub-id pub-id-type="pmid">21841821</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennan</surname><given-names>D</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Joubeh</surname><given-names>S</given-names></name><name><surname>Choi</surname><given-names>YW</given-names></name><name><surname>Whitaker-Menezes</surname><given-names>D</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>T</given-names></name><etal/></person-group><article-title>Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes</article-title><source>J Cell Sci</source><year>2007</year><volume>120</volume><fpage>758</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1242/jcs.03392</pub-id><pub-id pub-id-type="pmid">17284515</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raurell</surname><given-names>I</given-names></name><name><surname>Codina</surname><given-names>M</given-names></name><name><surname>Casagolda</surname><given-names>D</given-names></name><name><surname>Del Valle</surname><given-names>B</given-names></name><name><surname>Baulida</surname><given-names>J</given-names></name><name><surname>de Herreros</surname><given-names>AG</given-names></name><etal/></person-group><article-title>Gamma-secretase-dependent and -independent effects of presenilin1 on &#x003b2;-catenin.Tcf-4 transcriptional activity</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e4080</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0004080</pub-id><pub-id pub-id-type="pmid">19114997</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferber</surname><given-names>EC</given-names></name><name><surname>Kajita</surname><given-names>M</given-names></name><name><surname>Wadlow</surname><given-names>A</given-names></name><name><surname>Tobiansky</surname><given-names>L</given-names></name><name><surname>Niessen</surname><given-names>C</given-names></name><name><surname>Ariga</surname><given-names>H</given-names></name><etal/></person-group><article-title>A role for the cleaved cytoplasmic domain of E-cadherin in the nucleus</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>12691</fpage><lpage>700</lpage><pub-id pub-id-type="doi">10.1074/jbc.M708887200</pub-id><pub-id pub-id-type="pmid">18356166</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>C</given-names></name><name><surname>Choi</surname><given-names>JK</given-names></name><name><surname>Na</surname><given-names>YJ</given-names></name><name><surname>Jang</surname><given-names>B</given-names></name><name><surname>Wasco</surname><given-names>W</given-names></name><name><surname>Buxbaum</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Calsenilin regulates presenilin 1/&#x003b3;-secretase-mediated N-cadherin &#x003b5;-cleavage and &#x003b2;-catenin signaling</article-title><source>FASEB J</source><year>2011</year><volume>25</volume><fpage>4174</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1096/fj.11-185926</pub-id><pub-id pub-id-type="pmid">21852538</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maetzel</surname><given-names>D</given-names></name><name><surname>Denzel</surname><given-names>S</given-names></name><name><surname>Mack</surname><given-names>B</given-names></name><name><surname>Canis</surname><given-names>M</given-names></name><name><surname>Went</surname><given-names>P</given-names></name><name><surname>Benk</surname><given-names>M</given-names></name><etal/></person-group><article-title>Nuclear signalling by tumour-associated antigen EpCAM</article-title><source>Nat Cell Biol</source><year>2009</year><volume>11</volume><fpage>162</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1038/ncb1824</pub-id><pub-id pub-id-type="pmid">19136966</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utton</surname><given-names>MA</given-names></name><name><surname>Eickholt</surname><given-names>B</given-names></name><name><surname>Howell</surname><given-names>FV</given-names></name><name><surname>Wallis</surname><given-names>J</given-names></name><name><surname>Doherty</surname><given-names>P</given-names></name></person-group><article-title>Soluble N-cadherin stimulates fibroblast growth factor receptor dependent neurite outgrowth and N-cadherin and the fibroblast growth factor receptor co-cluster in cells</article-title><source>J Neurochem</source><year>2001</year><volume>76</volume><fpage>1421</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00140.x</pub-id><pub-id pub-id-type="pmid">11238727</pub-id></element-citation></ref><ref id="R95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Ren</surname><given-names>C</given-names></name><name><surname>Lindgren</surname><given-names>P</given-names></name><name><surname>Boman</surname><given-names>K</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells</article-title><source>Mol Endocrinol</source><year>2005</year><volume>19</volume><fpage>2564</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1210/me.2004-0342</pub-id><pub-id pub-id-type="pmid">15928314</pub-id></element-citation></ref><ref id="R96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampugnani</surname><given-names>MG</given-names></name><name><surname>Orsenigo</surname><given-names>F</given-names></name><name><surname>Gagliani</surname><given-names>MC</given-names></name><name><surname>Tacchetti</surname><given-names>C</given-names></name><name><surname>Dejana</surname><given-names>E</given-names></name></person-group><article-title>Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments</article-title><source>J Cell Biol</source><year>2006</year><volume>174</volume><fpage>593</fpage><lpage>604</lpage><pub-id pub-id-type="doi">10.1083/jcb.200602080</pub-id><pub-id pub-id-type="pmid">16893970</pub-id></element-citation></ref><ref id="R97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>HG</given-names></name><name><surname>Jenabi</surname><given-names>JM</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Keshelava</surname><given-names>N</given-names></name><name><surname>Shimada</surname><given-names>H</given-names></name><name><surname>May</surname><given-names>WA</given-names></name><etal/></person-group><article-title>E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase</article-title><source>Cancer Res</source><year>2007</year><volume>67</volume><fpage>3094</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-3259</pub-id><pub-id pub-id-type="pmid">17409416</pub-id></element-citation></ref><ref id="R98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pittard</surname><given-names>AJ</given-names></name><name><surname>Banks</surname><given-names>RE</given-names></name><name><surname>Galley</surname><given-names>HF</given-names></name><name><surname>Webster</surname><given-names>NR</given-names></name></person-group><article-title>Soluble E-cadherin concentrations in patients with systemic inflammatory response syndrome and multiorgan dysfunction syndrome</article-title><source>Br J Anaesth</source><year>1996</year><volume>76</volume><fpage>629</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1093/bja/76.5.629</pub-id><pub-id pub-id-type="pmid">8688260</pub-id></element-citation></ref><ref id="R99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katayama</surname><given-names>M</given-names></name><name><surname>Hirai</surname><given-names>S</given-names></name><name><surname>Kamihagi</surname><given-names>K</given-names></name><name><surname>Nakagawa</surname><given-names>K</given-names></name><name><surname>Yasumoto</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>I</given-names></name></person-group><article-title>Soluble E-cadherin fragments increased in circulation of cancer patients</article-title><source>Br J Cancer</source><year>1994</year><volume>69</volume><fpage>580</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1038/bjc.1994.106</pub-id><pub-id pub-id-type="pmid">8123491</pub-id></element-citation></ref><ref id="R100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sewpaul</surname><given-names>A</given-names></name><name><surname>French</surname><given-names>JJ</given-names></name><name><surname>Khoo</surname><given-names>TK</given-names></name><name><surname>Kernohan</surname><given-names>M</given-names></name><name><surname>Kirby</surname><given-names>JA</given-names></name><name><surname>Charnley</surname><given-names>RM</given-names></name></person-group><article-title>Soluble E-cadherin: an early marker of severity in acute pancreatitis</article-title><source>HPB Surg</source><year>2009</year><volume>2009</volume><fpage>397375</fpage><pub-id pub-id-type="doi">10.1155/2009/397375</pub-id><pub-id pub-id-type="pmid">19421334</pub-id></element-citation></ref><ref id="R101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname><given-names>JL</given-names></name><name><surname>Haas</surname><given-names>TL</given-names></name></person-group><article-title>Differential role of beta-catenin in VEGF and histamine-induced MMP-2 production in microvascular endothelial cells</article-title><source>J Cell Biochem</source><year>2009</year><volume>107</volume><fpage>272</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1002/jcb.22123</pub-id><pub-id pub-id-type="pmid">19306293</pub-id></element-citation></ref><ref id="R102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W</given-names></name><name><surname>Tan</surname><given-names>RJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Nie</surname><given-names>J</given-names></name><name><surname>Hou</surname><given-names>FF</given-names></name><etal/></person-group><article-title>Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/&#x003b2;-catenin activity in CKD</article-title><source>J Am Soc Nephrol</source><year>2012</year><volume>23</volume><fpage>294</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1681/ASN.2011050490</pub-id><pub-id pub-id-type="pmid">22095947</pub-id></element-citation></ref><ref id="R103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Kempen</surname><given-names>LC</given-names></name><name><surname>de Visser</surname><given-names>KE</given-names></name><name><surname>Coussens</surname><given-names>LM</given-names></name></person-group><article-title>Inflammation, proteases and cancer</article-title><source>Eur J Cancer</source><year>2006</year><volume>42</volume><fpage>728</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2006.01.004</pub-id><pub-id pub-id-type="pmid">16524717</pub-id></element-citation></ref><ref id="R104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chung</surname><given-names>Y</given-names></name><name><surname>Law</surname><given-names>S</given-names></name><name><surname>Kwong</surname><given-names>DL</given-names></name><name><surname>Luk</surname><given-names>JM</given-names></name></person-group><article-title>Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinoma</article-title><source>Dis Esophagus</source><year>2011</year><volume>24</volume><fpage>49</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1111/j.1442-2050.2010.01093.x</pub-id><pub-id pub-id-type="pmid">20807231</pub-id></element-citation></ref><ref id="R105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Derycke</surname><given-names>L</given-names></name><name><surname>De Wever</surname><given-names>O</given-names></name><name><surname>Stove</surname><given-names>V</given-names></name><name><surname>Vanhoecke</surname><given-names>B</given-names></name><name><surname>Delanghe</surname><given-names>J</given-names></name><name><surname>Depypere</surname><given-names>H</given-names></name><etal/></person-group><article-title>Soluble N-cadherin in human biological fluids</article-title><source>Int J Cancer</source><year>2006</year><volume>119</volume><fpage>2895</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1002/ijc.22219</pub-id><pub-id pub-id-type="pmid">16998833</pub-id></element-citation></ref><ref id="R106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffiths</surname><given-names>TR</given-names></name><name><surname>Brotherick</surname><given-names>I</given-names></name><name><surname>Bishop</surname><given-names>RI</given-names></name><name><surname>White</surname><given-names>MD</given-names></name><name><surname>McKenna</surname><given-names>DM</given-names></name><name><surname>Horne</surname><given-names>CH</given-names></name><etal/></person-group><article-title>Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence</article-title><source>Br J Cancer</source><year>1996</year><volume>74</volume><fpage>579</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1038/bjc.1996.404</pub-id><pub-id pub-id-type="pmid">8761373</pub-id></element-citation></ref><ref id="R107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Protheroe</surname><given-names>AS</given-names></name><name><surname>Banks</surname><given-names>RE</given-names></name><name><surname>Mzimba</surname><given-names>M</given-names></name><name><surname>Porter</surname><given-names>WH</given-names></name><name><surname>Southgate</surname><given-names>J</given-names></name><name><surname>Singh</surname><given-names>PN</given-names></name><etal/></person-group><article-title>Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer</article-title><source>Br J Cancer</source><year>1999</year><volume>80</volume><fpage>273</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6690351</pub-id><pub-id pub-id-type="pmid">10390008</pub-id></element-citation></ref><ref id="R108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilmanns</surname><given-names>C</given-names></name><name><surname>Grossmann</surname><given-names>J</given-names></name><name><surname>Steinhauer</surname><given-names>S</given-names></name><name><surname>Manthey</surname><given-names>G</given-names></name><name><surname>Weinhold</surname><given-names>B</given-names></name><name><surname>Schmitt-Gr&#x000e4;ff</surname><given-names>A</given-names></name><etal/></person-group><article-title>Soluble serum E-cadherin as a marker of tumour progression in colorectal cancer patients</article-title><source>Clin Exp Metastasis</source><year>2004</year><volume>21</volume><fpage>75</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1023/B:CLIN.0000017204.38807.22</pub-id><pub-id pub-id-type="pmid">15065605</pub-id></element-citation></ref><ref id="R109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiss</surname><given-names>JV</given-names></name><name><surname>Klein-Scory</surname><given-names>S</given-names></name><name><surname>K&#x000fc;bler</surname><given-names>S</given-names></name><name><surname>Reinacher-Schick</surname><given-names>A</given-names></name><name><surname>Stricker</surname><given-names>I</given-names></name><name><surname>Schmiegel</surname><given-names>W</given-names></name><etal/></person-group><article-title>Soluble E-cadherin as a serum biomarker candidate: elevated levels in patients with late-stage colorectal carcinoma and FAP</article-title><source>Int J Cancer</source><year>2011</year><volume>128</volume><fpage>1384</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1002/ijc.25438</pub-id><pub-id pub-id-type="pmid">20473926</pub-id></element-citation></ref><ref id="R110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>AO</given-names></name><name><surname>Lam</surname><given-names>SK</given-names></name><name><surname>Chu</surname><given-names>KM</given-names></name><name><surname>Lam</surname><given-names>CM</given-names></name><name><surname>Kwok</surname><given-names>E</given-names></name><name><surname>Leung</surname><given-names>SY</given-names></name><etal/></person-group><article-title>Soluble E-cadherin is a valid prognostic marker in gastric carcinoma</article-title><source>Gut</source><year>2001</year><volume>48</volume><fpage>808</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1136/gut.48.6.808</pub-id><pub-id pub-id-type="pmid">11358900</pub-id></element-citation></ref><ref id="R111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soyama</surname><given-names>A</given-names></name><name><surname>Eguchi</surname><given-names>S</given-names></name><name><surname>Takatsuki</surname><given-names>M</given-names></name><name><surname>Kawashita</surname><given-names>Y</given-names></name><name><surname>Hidaka</surname><given-names>M</given-names></name><name><surname>Tokai</surname><given-names>H</given-names></name><etal/></person-group><article-title>Significance of the serum level of soluble E-cadherin in patients with HCC</article-title><source>Hepatogastroenterology</source><year>2008</year><volume>55</volume><fpage>1390</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">18795696</pub-id></element-citation></ref><ref id="R112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charalabopoulos</surname><given-names>K</given-names></name><name><surname>Gogali</surname><given-names>A</given-names></name><name><surname>Dalavaga</surname><given-names>Y</given-names></name><name><surname>Daskalopoulos</surname><given-names>G</given-names></name><name><surname>Vassiliou</surname><given-names>M</given-names></name><name><surname>Bablekos</surname><given-names>G</given-names></name><etal/></person-group><article-title>The clinical significance of soluble E-cadherin in nonsmall cell lung cancer</article-title><source>Exp Oncol</source><year>2006</year><volume>28</volume><fpage>83</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">16614715</pub-id></element-citation></ref><ref id="R113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gogali</surname><given-names>A</given-names></name><name><surname>Charalabopoulos</surname><given-names>K</given-names></name><name><surname>Zampira</surname><given-names>I</given-names></name><name><surname>Konstantinidis</surname><given-names>AK</given-names></name><name><surname>Tachmazoglou</surname><given-names>F</given-names></name><name><surname>Daskalopoulos</surname><given-names>G</given-names></name><etal/></person-group><article-title>Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers</article-title><source>Chest</source><year>2010</year><volume>138</volume><fpage>1173</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1378/chest.10-0157</pub-id><pub-id pub-id-type="pmid">20495107</pub-id></element-citation></ref><ref id="R114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sundfeldt</surname><given-names>K</given-names></name><name><surname>Ivarsson</surname><given-names>K</given-names></name><name><surname>Rask</surname><given-names>K</given-names></name><name><surname>Haeger</surname><given-names>M</given-names></name><name><surname>Hedin</surname><given-names>L</given-names></name><name><surname>Br&#x000e4;nnstr&#x000f6;m</surname><given-names>M</given-names></name></person-group><article-title>Higher levels of soluble E-cadherin in cyst fluid from malignant ovarian tumours than in benign cysts</article-title><source>Anticancer Res</source><year>2001</year><volume>21</volume><issue>1A</issue><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">11299791</pub-id></element-citation></ref><ref id="R115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>OD</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Ariztia</surname><given-names>EV</given-names></name><name><surname>Wang</surname><given-names>FQ</given-names></name><name><surname>Smith</surname><given-names>PJ</given-names></name><name><surname>Hope</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Lysophosphatidic acid (LPA) promotes E-cadherin ectodomain shedding and OVCA429 cell invasion in an uPA-dependent manner</article-title><source>Gynecol Oncol</source><year>2008</year><volume>108</volume><fpage>361</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.ygyno.2007.10.027</pub-id><pub-id pub-id-type="pmid">18073130</pub-id></element-citation></ref><ref id="R116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuefer</surname><given-names>R</given-names></name><name><surname>Hofer</surname><given-names>MD</given-names></name><name><surname>Zorn</surname><given-names>CS</given-names></name><name><surname>Engel</surname><given-names>O</given-names></name><name><surname>Volkmer</surname><given-names>BG</given-names></name><name><surname>Juarez-Brito</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Assessment of a fragment of e-cadherin as a serum biomarker with predictive value for prostate cancer</article-title><source>Br J Cancer</source><year>2005</year><volume>92</volume><fpage>2018</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1038/sj.bjc.6602599</pub-id><pub-id pub-id-type="pmid">15870707</pub-id></element-citation></ref><ref id="R117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billion</surname><given-names>K</given-names></name><name><surname>Ibrahim</surname><given-names>H</given-names></name><name><surname>Mauch</surname><given-names>C</given-names></name><name><surname>Niessen</surname><given-names>CM</given-names></name></person-group><article-title>Increased soluble E-cadherin in melanoma patients</article-title><source>Skin Pharmacol Physiol</source><year>2006</year><volume>19</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1159/000091972</pub-id><pub-id pub-id-type="pmid">16685144</pub-id></element-citation></ref><ref id="R118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shirahama</surname><given-names>S</given-names></name><name><surname>Furukawa</surname><given-names>F</given-names></name><name><surname>Wakita</surname><given-names>H</given-names></name><name><surname>Takigawa</surname><given-names>M</given-names></name></person-group><article-title>E- and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer</article-title><source>J Dermatol Sci</source><year>1996</year><volume>13</volume><fpage>30</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/0923-1811(95)00493-9</pub-id><pub-id pub-id-type="pmid">8902651</pub-id></element-citation></ref><ref id="R119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velikova</surname><given-names>G</given-names></name><name><surname>Banks</surname><given-names>RE</given-names></name><name><surname>Gearing</surname><given-names>A</given-names></name><name><surname>Hemingway</surname><given-names>I</given-names></name><name><surname>Forbes</surname><given-names>MA</given-names></name><name><surname>Preston</surname><given-names>SR</given-names></name><etal/></person-group><article-title>Serum concentrations of soluble adhesion molecules in patients with colorectal cancer</article-title><source>Br J Cancer</source><year>1998</year><volume>77</volume><fpage>1857</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/bjc.1998.309</pub-id><pub-id pub-id-type="pmid">9667659</pub-id></element-citation></ref><ref id="R120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadducci</surname><given-names>A</given-names></name><name><surname>Ferdeghini</surname><given-names>M</given-names></name><name><surname>Cosio</surname><given-names>S</given-names></name><name><surname>Annicchiarico</surname><given-names>C</given-names></name><name><surname>Ciampi</surname><given-names>B</given-names></name><name><surname>Bianchi</surname><given-names>R</given-names></name><etal/></person-group><article-title>Preoperative serum E-cadherin assay in patients with ovarian carcinoma</article-title><source>Anticancer Res</source><year>1999</year><volume>19</volume><issue>1B</issue><fpage>769</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">10216491</pub-id></element-citation></ref><ref id="R121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manetti</surname><given-names>M</given-names></name><name><surname>Guiducci</surname><given-names>S</given-names></name><name><surname>Romano</surname><given-names>E</given-names></name><name><surname>Rosa</surname><given-names>I</given-names></name><name><surname>Ceccarelli</surname><given-names>C</given-names></name><name><surname>Mello</surname><given-names>T</given-names></name><etal/></person-group><article-title>Differential expression of junctional adhesion molecules in different stages of systemic sclerosis</article-title><source>Arthritis Rheum</source><year>2013</year><volume>65</volume><fpage>247</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1002/art.37712</pub-id><pub-id pub-id-type="pmid">23001478</pub-id></element-citation></ref><ref id="R122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streeck</surname><given-names>H</given-names></name><name><surname>Kwon</surname><given-names>DS</given-names></name><name><surname>Pyo</surname><given-names>A</given-names></name><name><surname>Flanders</surname><given-names>M</given-names></name><name><surname>Chevalier</surname><given-names>MF</given-names></name><name><surname>Law</surname><given-names>K</given-names></name><etal/></person-group><article-title>Epithelial adhesion molecules can inhibit HIV-1-specific CD8&#x0207a; T-cell functions</article-title><source>Blood</source><year>2011</year><volume>117</volume><fpage>5112</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1182/blood-2010-12-321588</pub-id><pub-id pub-id-type="pmid">21403126</pub-id></element-citation></ref><ref id="R123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishifuji</surname><given-names>K</given-names></name><name><surname>Shimizu</surname><given-names>A</given-names></name><name><surname>Ishiko</surname><given-names>A</given-names></name><name><surname>Iwasaki</surname><given-names>T</given-names></name><name><surname>Amagai</surname><given-names>M</given-names></name></person-group><article-title>Removal of amino-terminal extracellular domains of desmoglein 1 by staphylococcal exfoliative toxin is sufficient to initiate epidermal blister formation</article-title><source>J Dermatol Sci</source><year>2010</year><volume>59</volume><fpage>184</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/j.jdermsci.2010.07.010</pub-id><pub-id pub-id-type="pmid">20728315</pub-id></element-citation></ref><ref id="R124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnell</surname><given-names>U</given-names></name><name><surname>Kuipers</surname><given-names>J</given-names></name><name><surname>Giepmans</surname><given-names>BN</given-names></name></person-group><article-title>EpCAM proteolysis: new fragments with distinct functions?</article-title><source>Biosci Rep</source><year>2013</year><volume>33</volume><fpage>e00030</fpage><pub-id pub-id-type="doi">10.1042/BSR20120128</pub-id><pub-id pub-id-type="pmid">23409978</pub-id></element-citation></ref><ref id="R125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casas</surname><given-names>E</given-names></name><name><surname>Barron</surname><given-names>C</given-names></name><name><surname>Francis</surname><given-names>SA</given-names></name><name><surname>McCormack</surname><given-names>JM</given-names></name><name><surname>McCarthy</surname><given-names>KM</given-names></name><name><surname>Schneeberger</surname><given-names>EE</given-names></name><etal/></person-group><article-title>Cholesterol efflux stimulates metalloproteinase-mediated cleavage of occludin and release of extracellular membrane particles containing its C-terminal fragments</article-title><source>Exp Cell Res</source><year>2010</year><volume>316</volume><fpage>353</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2009.10.020</pub-id><pub-id pub-id-type="pmid">19854171</pub-id></element-citation></ref><ref id="R126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Gorodeski</surname><given-names>GI</given-names></name></person-group><article-title>Estrogen abrogates transcervical tight junctional resistance by acceleration of occludin modulation</article-title><source>J Clin Endocrinol Metab</source><year>2004</year><volume>89</volume><fpage>5145</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1210/jc.2004-0823</pub-id><pub-id pub-id-type="pmid">15472219</pub-id></element-citation></ref><ref id="R127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorodeski</surname><given-names>GI</given-names></name></person-group><article-title>Estrogen decrease in tight junctional resistance involves matrix-metalloproteinase-7-mediated remodeling of occludin</article-title><source>Endocrinology</source><year>2007</year><volume>148</volume><fpage>218</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1210/en.2006-1120</pub-id><pub-id pub-id-type="pmid">17038551</pub-id></element-citation></ref><ref id="R128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>MH</given-names></name><name><surname>Du</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Straubhaar</surname><given-names>J</given-names></name><name><surname>Languino</surname><given-names>LR</given-names></name><name><surname>Balaji</surname><given-names>KC</given-names></name></person-group><article-title>Protein kinase D1 inhibits cell proliferation through matrix metalloproteinase-2 and matrix metalloproteinase-9 secretion in prostate cancer</article-title><source>Cancer Res</source><year>2010</year><volume>70</volume><fpage>2095</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-4155</pub-id><pub-id pub-id-type="pmid">20160036</pub-id></element-citation></ref><ref id="R129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lynch</surname><given-names>CC</given-names></name><name><surname>Vargo-Gogola</surname><given-names>T</given-names></name><name><surname>Matrisian</surname><given-names>LM</given-names></name><name><surname>Fingleton</surname><given-names>B</given-names></name></person-group><article-title>Cleavage of E-Cadherin by Matrix Metalloproteinase-7 Promotes Cellular Proliferation in Nontransformed Cell Lines via Activation of RhoA</article-title><source>J Oncol</source><year>2010</year><volume>2010</volume><fpage>530745</fpage><pub-id pub-id-type="doi">10.1155/2010/530745</pub-id><pub-id pub-id-type="pmid">20628524</pub-id></element-citation></ref><ref id="R130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGuire</surname><given-names>JK</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Parks</surname><given-names>WC</given-names></name></person-group><article-title>Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium</article-title><source>Am J Pathol</source><year>2003</year><volume>162</volume><fpage>1831</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/S0002-9440(10)64318-0</pub-id><pub-id pub-id-type="pmid">12759241</pub-id></element-citation></ref><ref id="R131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Choi</surname><given-names>EY</given-names></name><name><surname>Hyun</surname><given-names>MS</given-names></name><name><surname>Jang</surname><given-names>BI</given-names></name><name><surname>Kim</surname><given-names>TN</given-names></name><name><surname>Kim</surname><given-names>SW</given-names></name><etal/></person-group><article-title>Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells</article-title><source>Eur Surg Res</source><year>2007</year><volume>39</volume><fpage>208</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1159/000101452</pub-id><pub-id pub-id-type="pmid">17396032</pub-id></element-citation></ref><ref id="R132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zuo</surname><given-names>JH</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>MY</given-names></name><name><surname>Li</surname><given-names>XH</given-names></name><name><surname>Yi</surname><given-names>H</given-names></name><name><surname>Zeng</surname><given-names>GQ</given-names></name><etal/></person-group><article-title>Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin</article-title><source>J Cell Biochem</source><year>2011</year><volume>112</volume><fpage>2508</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1002/jcb.23175</pub-id><pub-id pub-id-type="pmid">21557297</pub-id></element-citation></ref><ref id="R133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huguenin</surname><given-names>M</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>EJ</given-names></name><name><surname>Trachsel-R&#x000f6;smann</surname><given-names>S</given-names></name><name><surname>Oneda</surname><given-names>B</given-names></name><name><surname>Ambort</surname><given-names>D</given-names></name><name><surname>Sterchi</surname><given-names>EE</given-names></name><etal/></person-group><article-title>The metalloprotease meprinbeta processes E-cadherin and weakens intercellular adhesion</article-title><source>PLoS One</source><year>2008</year><volume>3</volume><fpage>e2153</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0002153</pub-id><pub-id pub-id-type="pmid">18478055</pub-id></element-citation></ref><ref id="R134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maretzky</surname><given-names>T</given-names></name><name><surname>Scholz</surname><given-names>F</given-names></name><name><surname>K&#x000f6;ten</surname><given-names>B</given-names></name><name><surname>Proksch</surname><given-names>E</given-names></name><name><surname>Saftig</surname><given-names>P</given-names></name><name><surname>Reiss</surname><given-names>K</given-names></name></person-group><article-title>ADAM10-mediated E-cadherin release is regulated by proinflammatory cytokines and modulates keratinocyte cohesion in eczematous dermatitis</article-title><source>J Invest Dermatol</source><year>2008</year><volume>128</volume><fpage>1737</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1038/sj.jid.5701242</pub-id><pub-id pub-id-type="pmid">18200054</pub-id></element-citation></ref><ref id="R135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schirrmeister</surname><given-names>W</given-names></name><name><surname>Gnad</surname><given-names>T</given-names></name><name><surname>Wex</surname><given-names>T</given-names></name><name><surname>Higashiyama</surname><given-names>S</given-names></name><name><surname>Wolke</surname><given-names>C</given-names></name><name><surname>Naumann</surname><given-names>M</given-names></name><etal/></person-group><article-title>Ectodomain shedding of E-cadherin and c-Met is induced by Helicobacter pylori infection</article-title><source>Exp Cell Res</source><year>2009</year><volume>315</volume><fpage>3500</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.yexcr.2009.07.029</pub-id><pub-id pub-id-type="pmid">19665015</pub-id></element-citation></ref><ref id="R136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solanas</surname><given-names>G</given-names></name><name><surname>Cortina</surname><given-names>C</given-names></name><name><surname>Sevillano</surname><given-names>M</given-names></name><name><surname>Batlle</surname><given-names>E</given-names></name></person-group><article-title>Cleavage of E-cadherin by ADAM10 mediates epithelial cell sorting downstream of EphB signalling</article-title><source>Nat Cell Biol</source><year>2011</year><volume>13</volume><fpage>1100</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/ncb2298</pub-id><pub-id pub-id-type="pmid">21804545</pub-id></element-citation></ref><ref id="R137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>CF</given-names></name><name><surname>Hostetter</surname><given-names>MK</given-names></name></person-group><article-title>Cleavage of E-cadherin: a mechanism for disruption of the intestinal epithelial barrier by Candida albicans</article-title><source>Transl Res</source><year>2007</year><volume>149</volume><fpage>211</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.trsl.2006.11.006</pub-id><pub-id pub-id-type="pmid">17383595</pub-id></element-citation></ref><ref id="R138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klucky</surname><given-names>B</given-names></name><name><surname>Mueller</surname><given-names>R</given-names></name><name><surname>Vogt</surname><given-names>I</given-names></name><name><surname>Teurich</surname><given-names>S</given-names></name><name><surname>Hartenstein</surname><given-names>B</given-names></name><name><surname>Breuhahn</surname><given-names>K</given-names></name><etal/></person-group><article-title>Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion</article-title><source>Cancer Res</source><year>2007</year><volume>67</volume><fpage>8198</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-0607</pub-id><pub-id pub-id-type="pmid">17804733</pub-id></element-citation></ref><ref id="R139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayerle</surname><given-names>J</given-names></name><name><surname>Schnekenburger</surname><given-names>J</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>B</given-names></name><name><surname>Kellermann</surname><given-names>J</given-names></name><name><surname>Ruthenb&#x000fc;rger</surname><given-names>M</given-names></name><name><surname>Weiss</surname><given-names>FU</given-names></name><etal/></person-group><article-title>Extracellular cleavage of E-cadherin by leukocyte elastase during acute experimental pancreatitis in rats</article-title><source>Gastroenterology</source><year>2005</year><volume>129</volume><fpage>1251</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2005.08.002</pub-id><pub-id pub-id-type="pmid">16230078</pub-id></element-citation></ref><ref id="R140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gocheva</surname><given-names>V</given-names></name><name><surname>Zeng</surname><given-names>W</given-names></name><name><surname>Ke</surname><given-names>D</given-names></name><name><surname>Klimstra</surname><given-names>D</given-names></name><name><surname>Reinheckel</surname><given-names>T</given-names></name><name><surname>Peters</surname><given-names>C</given-names></name><etal/></person-group><article-title>Distinct roles for cysteine cathepsin genes in multistage tumorigenesis</article-title><source>Genes Dev</source><year>2006</year><volume>20</volume><fpage>543</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1101/gad.1407406</pub-id><pub-id pub-id-type="pmid">16481467</pub-id></element-citation></ref><ref id="R141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dusek</surname><given-names>RL</given-names></name><name><surname>Getsios</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Park</surname><given-names>JK</given-names></name><name><surname>Amargo</surname><given-names>EV</given-names></name><name><surname>Cryns</surname><given-names>VL</given-names></name><etal/></person-group><article-title>The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes</article-title><source>J Biol Chem</source><year>2006</year><volume>281</volume><fpage>3614</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1074/jbc.M508258200</pub-id><pub-id pub-id-type="pmid">16286477</pub-id></element-citation></ref><ref id="R142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundstr&#x000f6;m</surname><given-names>A</given-names></name><name><surname>Egelrud</surname><given-names>T</given-names></name></person-group><article-title>Evidence that cell shedding from plantar stratum corneum in vitro involves endogenous proteolysis of the desmosomal protein desmoglein I</article-title><source>J Invest Dermatol</source><year>1990</year><volume>94</volume><fpage>216</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1111/1523-1747.ep12874531</pub-id><pub-id pub-id-type="pmid">1688905</pub-id></element-citation></ref><ref id="R143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klessner</surname><given-names>JL</given-names></name><name><surname>Desai</surname><given-names>BV</given-names></name><name><surname>Amargo</surname><given-names>EV</given-names></name><name><surname>Getsios</surname><given-names>S</given-names></name><name><surname>Green</surname><given-names>KJ</given-names></name></person-group><article-title>EGFR and ADAMs cooperate to regulate shedding and endocytic trafficking of the desmosomal cadherin desmoglein 2</article-title><source>Mol Biol Cell</source><year>2009</year><volume>20</volume><fpage>328</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1091/mbc.E08-04-0356</pub-id><pub-id pub-id-type="pmid">18987342</pub-id></element-citation></ref><ref id="R144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santiago-Josefat</surname><given-names>B</given-names></name><name><surname>Esselens</surname><given-names>C</given-names></name><name><surname>Bech-Serra</surname><given-names>JJ</given-names></name><name><surname>Arribas</surname><given-names>J</given-names></name></person-group><article-title>Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><fpage>8325</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1074/jbc.M608826200</pub-id><pub-id pub-id-type="pmid">17227756</pub-id></element-citation></ref><ref id="R145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramani</surname><given-names>VC</given-names></name><name><surname>Hennings</surname><given-names>L</given-names></name><name><surname>Haun</surname><given-names>RS</given-names></name></person-group><article-title>Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer</article-title><source>BMC Cancer</source><year>2008</year><volume>8</volume><fpage>373</fpage><pub-id pub-id-type="doi">10.1186/1471-2407-8-373</pub-id><pub-id pub-id-type="pmid">19091121</pub-id></element-citation></ref><ref id="R146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weiske</surname><given-names>J</given-names></name><name><surname>Sch&#x000f6;neberg</surname><given-names>T</given-names></name><name><surname>Schr&#x000f6;der</surname><given-names>W</given-names></name><name><surname>Hatzfeld</surname><given-names>M</given-names></name><name><surname>Tauber</surname><given-names>R</given-names></name><name><surname>Huber</surname><given-names>O</given-names></name></person-group><article-title>The fate of desmosomal proteins in apoptotic cells</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>41175</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1074/jbc.M105769200</pub-id><pub-id pub-id-type="pmid">11500511</pub-id></element-citation></ref><ref id="R147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Covington</surname><given-names>MD</given-names></name><name><surname>Burghardt</surname><given-names>RC</given-names></name><name><surname>Parrish</surname><given-names>AR</given-names></name></person-group><article-title>Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14)</article-title><source>Am J Physiol Renal Physiol</source><year>2006</year><volume>290</volume><fpage>F43</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1152/ajprenal.00179.2005</pub-id><pub-id pub-id-type="pmid">16077081</pub-id></element-citation></ref><ref id="R148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>CB</given-names></name><name><surname>Yun</surname><given-names>SM</given-names></name><name><surname>Jo</surname><given-names>C</given-names></name><name><surname>Koh</surname><given-names>YH</given-names></name></person-group><article-title>&#x003b3;-Secretase-dependent cleavage of E-cadherin by staurosporine in breast cancer cells</article-title><source>Cell Commun Adhes</source><year>2012</year><volume>19</volume><fpage>11</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.3109/15419061.2012.665969</pub-id><pub-id pub-id-type="pmid">22401168</pub-id></element-citation></ref><ref id="R149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmeiser</surname><given-names>K</given-names></name><name><surname>Grand</surname><given-names>RJ</given-names></name></person-group><article-title>The fate of E- and P-cadherin during the early stages of apoptosis</article-title><source>Cell Death Differ</source><year>1999</year><volume>6</volume><fpage>377</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4400504</pub-id><pub-id pub-id-type="pmid">10381631</pub-id></element-citation></ref><ref id="R150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>DY</given-names></name><name><surname>Ingano</surname><given-names>LA</given-names></name><name><surname>Kovacs</surname><given-names>DM</given-names></name></person-group><article-title>Nectin-1&#x003b1;, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for presenilin/&#x003b3;-secretase-like cleavage</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>49976</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1074/jbc.M210179200</pub-id><pub-id pub-id-type="pmid">12376527</pub-id></element-citation></ref></ref-list></back></article>